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Kalyn Marie Renbarger 
THE HEALTH CARE ENCOUNTERS OF PREGNANT AND POSTPARTUM 
WOMEN WITH SUBSTANCE USE DISORDERS 
Pregnant and postpartum women with substance use disorders (SUDs) are likely 
to experience adverse health care encounters that contribute to poor health outcomes for 
them and their infants.  The purpose of this dissertation is to describe the health care 
encounters of pregnant and postpartum women with SUDs.  This dissertation includes 
two studies.  The first study is a metasynthesis of published qualitative studies using a 
metasummary approach to classify the types of health care encounters experienced by 
pregnant and postpartum women with SUDs.  A taxonomy of health care encounters was 
developed.  Five types of adverse encounters were identified and labeled as (a) 
judgmental, (b) disparaging, (c) scrutinizing, (d) disempowering, and (e) deficient care.  
Three types of beneficial encounters were identified and labeled as (a) recovery-based, 
(b) accepting, and (c) effective care.  The second study was a qualitative descriptive study 
conducted to describe factors that influence the formation of trusting relationships 
between maternity nurses and pregnant and postpartum women with SUDs.  Interviews 
with 15 maternity nurses and 10 pregnant and postpartum women with SUDs were 
conducted.  Content analysis of the participant narratives revealed a number of 
characteristics of maternity nurses and pregnant and postpartum women with SUDs that 
helped or hindered trusting relationships.  Six characteristics of maternity nurses were 
identified and labeled as (a) rapport-building with women, (b) demeanor toward women, 
(c) provision of care, (d) provision of information, (e) attitude toward substance use, and 
(f) addiction expertise.  Five characteristics of the women were identified and labeled as 
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(a) engagement with nurses, (b) demeanor toward nurses, (c) acceptance of care, (d) 
investment in recovery, and (e) bonding with infant.  Adverse encounters were often 
associated with provider stigma related to substance use during pregnancy and limited 
provider knowledge related to addiction.  The findings will contribute to the development 
of strategies to improve the health care encounters of this population by promoting 
stigma awareness and communication skills training.  
Claire Burke Draucker, PhD, RN, FAAN, Chair 
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CHAPTER 1 
Introduction 
 This chapter provides an introduction to the dissertation research, which includes 
two studies: a metasummary (Study 1) and a qualitative descriptive study (Study 2).  The 
chapter includes a discussion of the background and significance of the research topic, 
the purpose and specific aims of the studies, a description of the methods of the studies, 
an overview of the nursing theory most relevant to the dissertation, and a brief summary 
of chapters 2 through 4. 
Background and Significance 
Prenatal Substance Use 
 Prenatal substance use is a significant public health problem that has a variety of 
negative health implications for women and children.  In 2018, a U.S. national survey 
indicated that 11.6% of pregnant women reported tobacco use, 9.9% heavy alcohol use, 
and 5.4% illicit drug use in the past month (U.S. Department of Health and Human 
Services, 2019).  The type of substance as well as the timing and degree of use in 
pregnancy affect maternal and infant health outcomes (Forray, 2016).  
  According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition, substance use disorders (SUDs) are problematic patterns of substance use that 
result in impairment or distress.  SUDs are classified as mild, moderate, or severe.  
Common SUDs include opioid use disorder, alcohol use disorder, and cannabis use 
disorder.  SUDs are diagnosed based on evidence of 11 symptoms related to impaired 
control, social impairment, risky use, and pharmacological criteria (American Psychiatric 
Association, 2013).  
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 Substance use during pregnancy is linked to a number of maternal, fetal, and 
neonatal complications.  These complications include increased risk of abruption 
placenta, infant mortality, intrauterine growth restrictions, low infant birth weight, 
neonate withdrawal symptoms, still birth, and preterm birth (Cook et al., 2017; Forray, 
2016; O'Leary et al., 2012; Patrick et. al., 2017; Salihu & Wilson, 2007; Shankaran et al., 
2007; Yazdy et al., 2015).  Moreover, substance use during pregnancy is associated with 
a number of psychosocial consequences for mothers and infants.  For example, maternal 
substance use has been identified as a risk for poor mother-infant attachment, which is 
associated with child maltreatment (Solis et al., 2012).  According to the Adoption and 
Foster Care Analysis and Reporting System (AFCARS), 269,509 children entered the 
foster care system in the United States in 2018, and drug abuse by a parent was listed as 
the main reason for child removal in 36% of the cases (U.S. Department of Health and 
Human Services, 2019). 
Prenatal Substance Use in the Context of the National Opioid Epidemic 
 Opioid use in the United States has become a major public health concern and   
has contributed to maternal and child health concerns in the United States (Centers for 
Disease Control and Prevention, 2007).  For example, one study found approximately one 
in five women (21.6%) in a sample of over 1.1 million women in 46 states and 
Washington D.C who were enrolled in Medicaid filled a prescription for an opioid during 
pregnancy.  The rate of filled opioid prescriptions increased from 18.5% in 2000 to 
22.8% in 2007 (Desai et al., 2014).  Between the years of 1999 and 2014, rates of opioid 
use during pregnancy increased dramatically from 1.5 cases per 1,000 hospital births to 
6.5 cases per 1,000 hospital births (Haight et al., 2018).  Additionally, during the time 
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period between 2000 and 2013, rates of heroin use in women doubled in the United States 
(Jones et al., 2015).  The increase in opioid use during pregnancy has resulted in a 
dramatic rise in the number of women seeking substance use treatment.  From 1992 to 
2012, the percent of pregnant women admitted to substance use treatment facilities who 
reported a history of prescription opioid misuse increased from 2% to 28% (Martin et al., 
2015).  
Neonatal Abstinence Syndrome 
 Neonatal abstinence syndrome (NAS) has become a major maternal child health 
problem as a consequence of the national opioid epidemic.  As many as 75-90% of 
infants exposed to prenatal opioids will experience NAS.  NAS is a set of withdrawal 
symptoms including irritability, excessive crying, and tremors that are experienced by 
newborns exposed to opioids and other substances during pregnancy (Hudak & Tan, 
2012).  In addition to opioids, withdrawal symptoms can occur in infants with prenatal 
exposure to benzodiazepines, barbiturates, alcohol, and certain antidepressants.  Other 
substances such as cocaine, amphetamines, and nicotine may increase the severity of 
NAS symptoms (Hudak & Tan, 2012).  Based on data from hospital births in 28 states in 
the United States, it was estimated that NAS increased by 300% between the years of 
1999 and 2013.  The overall incidence of NAS during this time period was 2.5 cases per 
1,000 hospital births.  In 1999, the incidence of NAS was 1.5 cases per 1,000 hospital 
births, and in 2013, the incidence was 6.0 cases per 1,000 hospital births (based on 21 
reporting states) (Ko et al., 2016).  NAS can result in extended length of hospital stay and 
increased hospital costs.  Between 2004 and 2014, the total hospital costs in the United 
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States related to NAS increased from $65.4 million to $462 million per year (Winkelman 
et al., 2018).  
Substance Use and Health Care Experiences in Pregnancy and Postpartum 
 Pregnant and postpartum women with SUDs often report problematic 
relationships with health care providers.  For example, studies have shown that pregnant 
and postpartum women with SUDs often do not have trusting relationships with health 
care providers and sometimes opt to avoid health care (Hall & Teijlingen, 2006; Roberts 
& Pies, 2011).  Patients’ trust that a health care provider cares about them and works in 
their best interest is considered foundational to the provider-patient relationship and is 
associated with positive health outcomes (Birkhauer et al., 2017).  When pregnant and 
postpartum women and health care providers do not form trusting relationships, 
inadequate prenatal care and missed opportunities to improve health outcomes for women 
and their infants can result (Chan & Moriarty, 2010; Gilchrist et al., 2012; Leppo, 2012).  
Two factors that influence the formation of trust between health care providers and 
pregnant and postpartum women with SUDs are stigma and criminalization of substance 
use during pregnancy. 
 Stigma.  Pregnant and postpartum women with SUDs experience stigma in their 
encounters with health care providers (Cleveland & Bonguli, 2014; Cleveland & Gill, 
2013; Gilchrist et al., 2012; Hall & van Teijlingen, 2006; Howard, 2015; Leppo, 2012; 
McGlothen et al., 2018; Paterno et al., 2018).  Sociologist Erving Goffman (1963), a 
leading theorist on stigma, defined stigma as “an attribute that is deeply discrediting” (p. 
3) and argued that stigma leads to low self-esteem, depression, and isolation (Goffman, 
1963).  Health conditions often associated with stigma include skin conditions, epilepsy, 
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sexually transmitted diseases, substance use, and mental illness (Knaak et al., 2017; van 
Boekel et al., 2013; Van Brakel, 2006). 
 Pregnant women and postpartum women with SUDs experience stigma through 
judgmental attitudes expressed by health care providers.  The women report that because 
they use substances providers undermine their decision-making, refer to them with 
negative labels (e.g., “methadone mom”) and provide differential treatment for them, 
thereby the impairing formation of trust (Demirci et al., 2015; Howard, 2015; Howard, 
2016; Jessup et al., 2003; Leppo, 2012).  Perceived stigma has been associated with 
increased substance use and dissatisfaction with pregnancy (Best et al., 2014) and 
decreased utilization of prenatal health care (Gilchrist et al., 2012; Hall & Teijlingen, 
2006).  Failure to receive prenatal care can impair health outcomes as health care services 
and addiction treatment are linked to decreased substance use during pregnancy and 
positive effects on maternal and newborn health (Goler et al., 2008).   
 Criminalization.  Criminalization of substance use during pregnancy and 
punitive policies such child removal, arrest, and incarceration can impact the health care 
experiences of pregnant and postpartum women with SUDs.  Most states do not have a 
statute that directly criminalizes substance use during pregnancy, but existing laws have 
been used to punish women who use substances while pregnant (Guttmacher Institute, 
2019).  For example, several states have laws that state an infant exposed prenatally to 
substances is believed to be abused or neglected and a positive toxicology test can be 
used as evidence for terminating parental rights (Guttmacher Institute, 2019).  Efforts to 
improve availability and accessibility of substance use treatment programs have often 
lagged behind efforts to criminalize substance use during pregnancy (Krans & Patrick, 
6 
2016).  Only19 states have created or funded substance use treatment programs for 
pregnant women (Guttmacher Institute, 2019).  
 Pregnant and postpartum women with SUDs report fear of criminalization or 
punishment if their substance use is reported to authorities by health care providers (Chan 
& Moriarty, 2010; Gilchrist et al., 2012; Hall & van Teijlingen, 2006; Harvey et al., 
2015; Howard, 2015; Jessup et al., 2003; Leppo, 2012; Stone, 2015).  Fear of loss of 
infant custody, arrest, prosecution, or incarceration can thus impair the formation of trust 
in the provider-patient relationship, serve as a barrier to the utilization of prenatal care 
and addiction treatment services, and discourage disclosure of substance use to health 
care providers (Kruk & Banga, 2011; Phillips et al., 2007; Roberts & Nuru-Jeter, 2010; 
Roberts & Pies, 2011; Stengel, 2014; Stone, 2015; Van Scoyoc et al., 2016).  
Relationships Between Maternity Nurses and Women with SUDs  
 Maternity nurses play an important role in the health care of pregnant and 
postpartum women with SUDs and their infants.  Nurses are well situated to create a 
positive health care experience for women during pregnancy, labor and delivery, and 
postpartum by establishing a trusting relationship and enhancing the physical and 
emotional wellbeing of women and their families (Lyndon, 2009).  Research shows that 
new mothers’ satisfaction with maternity care is influenced by the quality of their 
relationships with a nurse (Peterson et al., 2007) and women’s perceptions of readiness 
for discharge in postpartum is linked to the quality of discharge teaching they receive 
from a nurse (Weiss & Lokken, 2009).   
 Despite the importance of the relationships between maternity nurses and 
pregnant and postpartum women, these relationships may be challenged when the women 
7 
use substances.  Maternity nurses may experience frustration towards women with SUDs 
and remain emotionally distance from them, resulting in workplace stress and burnout 
(Fraser et al., 2007; Maguire et al., 2012; Murphy-Oikonen et al., 2010; Shaw et al., 
2016).   
 Pregnant and postpartum women with SUDs also have described difficulties in 
their relationship to maternity nurses.  Pregnant and postpartum women with SUDs often 
report feeling unwelcomed and out of place when entering the neonatal intensive care 
unit (NICU) to care for their infants and have the sense nurses think the women are bad 
mothers and resent providing care to them (Cleveland & Gill, 2013).  
Purpose and Specific Aims 
 While the quality of provider-patient relationships is central to the care of 
pregnant and post-partum women with SUDs and influences their health outcomes, few 
studies have provided an in-depth description of health care encounters between 
providers and the women.  Specifically, little is known about factors that help or hinder 
the formation of trust between women with SUDs and the maternity nurses who provide a 
significant amount of their care.  Therefore, the purpose of the dissertation project is to 
describe the health care encounters of pregnant and postpartum women with SUDs, 
focusing on the formation of trusting relationships between maternity nurses and the 
women.  The specific aims include the following:  
Aim 1: Synthesize existing qualitative studies to describe how pregnant and 
postpartum women with SUDs experience health care encounters in prenatal care, 
labor and delivery, postpartum, and nursery/NICU settings.  
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 Aim 2: Identify facilitators of and barriers to the formation of trusting 
 relationships between maternity nurses and pregnant and postpartum women 
 with SUDs from the perspectives of the maternity nurses.  
 Aim 3: Identify facilitators of and barriers to the formation of trusting 
 relationships between maternity nurses and pregnant and postpartum women 
 with SUDs from the perspectives of the women.  
Theoretical Foundation of Dissertation: Theory of Interpersonal Relations 
 The theory that provides the theoretical foundation of this dissertation is 
Hildegard Peplau’s theory of interpersonal relations (1952, 1988, 1997).  Hildegard 
Peplau was a leading nurse theorist who was a pioneer in the field of psychiatric mental 
health nursing.  Peplau (1997) recognized the significance of the nurse-patient 
relationship in meeting a patient’s needs for connection.  She argued that the nurse-
patient relationship is the primary relationship during a patient’s hospital stay and 
considered trust to be an essential component of the nurse-patient relationship.  Peplau 
implored nurses to consider patients as persons rather than as medical conditions.  She 
stressed that nurses could not be effective without having adequate information about 
what is important to patients.  The theory indicates that the unfolding of nurse-patient 
relationships is unique to each dyad but share a similar structure (Peplau, 1997).  The 
structure, which serves as the basis of the theory, consists of three phases: the orientation 
phase, working phase, and termination phase. 
 The first phase of Peplau’s theory (1988) is the orientation phase.  During this 
phase, the nurse listens to the patient, gathers health information from the patient, and 
seeks additional information to get to know the patient as a person.  The nurse asks 
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questions in an attempt to fully capture the patient’s narrative.  The nurse guides the 
interactions to promote a reciprocal, professional relationship with the patient.  
Difficulties due to preconceptions of both the nurse and patient in the orientation phase 
can complicate the nurse-patient relationship.  However, the responsibility belongs to the 
nurse to examine his or her preconceptions about the patient in order to minimize their 
effects on the nurse-patient relationship.   
 The second phase of Peplau’s theory (1988) is the working phase.  The 
development of the nurse-patient relationship occurs primarily during this phase.  The 
nurse looks for cues of patient readiness to transition from the orientation phase to the 
working phase.  The transition occurs as the nurse begins to focus on the patient’s 
reactions to illness and what the patient must do to improve his or her health condition.  
Nurses serve several roles in the working phase including providing physical care, health 
teaching, interviewing, and counseling.   
 The third phase is the termination phase.  This phase represents the end of the 
professional relationship once the patient's needs have been met (Peplau, 1988).  This 
phase involves summarizing the work that has been accomplished and providing closure 
to the nurse-patient relationship.  Preparing for the termination phase involves completing 
the discharge planning that began in the working phase.  
 According to Peplau (1997), the nurse can face many challenges in establishing 
the nurse-patient relationship.  Some of these challenges include unfavorable 
comparisons of the patient with another person, avoiding rather than dealing with anger 
or annoyance toward patients, using disrespectful modes of addressing patients, and 
avoiding discussing emotional topics with patients.   
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 Peplau’s theory of interpersonal relations (1997) provides the contextual and 
theoretical basis for research on the relationship between maternity nurses and pregnant 
and postpartum women with SUDs for several reasons.  The theory is the best known 
nursing theory for describing the nurse-patient relationship, which is the central 
phenomenon explored in this dissertation.  Moreover, Peplau addressed facilitators and 
barriers associated with the formation of trusting nurse-patient relationships, as is 
consistent with dissertation aims.  The theory is also relevant to this work as it reflects 
how the nurse-patient relationship develops over time and focuses on the common 
challenges to the relationships.   
Methods 
 To accomplish the aims of the dissertation, two studies were conducted.  Study 1 
was a metasummary of published qualitative studies about how pregnant and postpartum 
women with SUDs experience health care encounters in prenatal care, labor and delivery, 
postpartum, and nursery/NICU settings.  While the focus of the dissertation is on the 
establishment of trust between maternity nurses and these women, Study 1 was 
conducted to provide a broader context within which to situate the findings of Study 2 by 
focusing on encounters with a variety of health care providers.  Study 2 was an empirical 
qualitative descriptive study to identify facilitators and barriers associated with the 
formation of trusting relationships between pregnant maternity nurses and postpartum 
women with SUDs.  A summary of the methods used to conduct Study 1 and Study 2 are 
described below. 
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Study 1 
 Study 1 was conducted to address Aim 1.  Qualitative metasummary as described 
by Sandelowski (2003) was used for this study.  Qualitative metasummary is a form of 
systematic review that combines qualitative findings from published studies to produce a 
straightforward summary of their findings at a topical or thematic level.  Topical and 
thematic summaries are findings that reflect lower levels of abstraction versus more 
highly interpretive findings such as those from grounded theories, phenomenologies, and 
ethnographies (Sandelowski & Barroso, 2007).  Metasummaries produce results that have 
practical policy and practice implications.  
 The qualitative metasummary included the following stages.  First, research 
articles that met study criteria (i.e., qualitative methods were used to describe encounters 
between health care providers and pregnant and postpartum women with SUDs) were 
retrieved and a cross study display table with basic study information (e.g., citation, 
purpose, sample, setting) was created.  Second, the findings of the studies were extracted.  
Third, the findings were edited into declarative statements that could be understood 
independent of the reports.  Fourth, the edited findings were grouped and abstracted 
statements that summarized them were written.  Next, effect sizes were used to calculate 
the frequency with which each finding appeared in the articles.  Fifth, a taxonomy of 
health care encounters was developed to identify types of health care encounters 
experienced by the participants in the studies.  The results and conclusions of Study 1 
appear in Chapter 2 of this document. 
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Study 2 
 Study 2 was conducted to address Aims 2 and 3.  A qualitative descriptive method 
was used for this study.  Qualitative description is a research approach used to produce 
low-interpretive findings that focus on the surface meaning of the participants’ words to 
describe a phenomenon from their perspectives (Sandelowski, 2000).  The approach 
provides a straightforward summary of narrative data in a format that can be used to 
provide information needed by policy makers and health care providers to address health 
care concerns (Sandelowski, 2000).  Because qualitative description provides a 
comprehensive summary rather than abstract conceptualizations of data, semi-structured 
interviews with individuals or groups are commonly used to obtain participant narratives 
(Neergaard et al., 2009). 
 Two groups were included in Study 2.  The first group included 15 maternity 
nurses recruited from a local Chapter of the Association of Women’s Health, Obstetric, 
and Neonatal Nursing (AWHONN).  AWHONN is a nonprofit, national membership 
nursing organization that promotes the health of women and newborns.  The nurses had 
at least one year of experience working in a maternity nursing area thereby ensuring they 
had interactions with pregnant and postpartum women with SUDs.  The second group 
included 10 women recruited from a residential maternal treatment center for substance 
use located in the Midwest.  The treatment center serves women with addictions and 
allows the women and their children to reside together while the women receive SUD 
treatment.  The women were 18 years or older, used substances during their pregnancy, 
and had given birth to a living child in the hospital setting within the 2 years prior to the 
interviews.   
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Interviews based on a semi-structured interview guide were conducted with both 
groups.  The participants were asked to describe nurse-patient encounters they had 
experienced while providing care to women or receiving care from nurses during 
pregnancy and postpartum, focusing on factors that influenced the development of trust.  
The interviews were recorded and transcribed.  
 The findings of interviews from both groups were merged and analyzed using 
standard content analysis.  The analysis included six steps.  First, the transcripts were 
read in their entirety to obtain a holistic understanding of the participants’ overall 
experiences.  Second, text units (i.e., meaningful words, phrases, sentences) related to the 
relationship between the maternity nurses and the women were extracted.  Third, a code 
was assigned to each text unit to capture its essence.  Fourth, the codes were displayed in 
a case-by-topic display table.  Fifth, the codes were categorized and summarized.  Sixth, 
a narrative description of each category addressing the study aims was written.  The 
results and conclusions of Study 2 appear in Chapter 3 of this document. 
Concepts and Definitions 
 The major concepts of this study are defined in Table 1.1 and Table 1.2.  Table 
1.1 defines terms related to the substantive content of the dissertation, and Table 1.2 
defines terms related to the methodological approaches used in Study 1 and Study 2.   
Table 1.1  
Terms Related to Substantive Content of Dissertation 
 
Substantive Term Definition 
Substance Any psychoactive compound that affects 
mental processes. Substances may be 
legal, illegal, or controlled (World Health 
Organization, 2019).  
Substance use 
 
The use of a substance for nonmedical 
purposes that may cause health and social 
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Substantive Term Definition 
 problems (World Health Organization, 
2019). 
Substance use disorder 
 
 
 
 
A problematic pattern of substance use 
that is diagnosed based on evidence of 
impaired control, social impairment, risky  
use, and pharmacological criteria 
(American Psychiatric Association, 2013) 
 
Opioid A class of substances derived from the 
opium poppy and their synthetic 
equivalents that have the ability to relieve 
pain and produce euphoria. Opioids 
include morphine, heroin, oxycodone, and 
methadone (World Health Organization, 
2019).   
Pregnancy/prenatal Time period before birth in which a fetus 
develops inside a woman's womb or 
uterus and usually lasts around 40 weeks 
(National Institute of Child Health and 
Human Development, 2018). 
Postpartum Time period that begins immediately after 
birth when maternal physiological 
changes related to pregnancy return to the 
non-pregnant state. The end of this period 
is less defined and has been considered to 
be up to 12 months. (Berens, 2018).  
Maternity nurse A nursing professional who provides care 
to a pregnant woman and her child before, 
during, or after the birth. Maternity nurses 
work in prenatal, labor and delivery, 
postpartum, and NICU settings.  
NAS A cluster of withdrawal symptoms that 
effect the central nervous, gastrointestinal, 
and respiratory systems of newborns 
exposed to opioids and other substances 
during pregnancy (Hudak & Tan, 2012). 
Stigma A discrediting attitude by others based on 
a person’s characteristics or 
circumstances (Goffman, 1963, p.3) 
Criminalization related to pregnancy 
 
 
 
 
 
Incarceration or other punitive legal 
actions against women who use 
substances during pregnancy (Amnesty 
International, 2017). 
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Substantive Term Definition 
Trust in provider-patient relationships A response to a health care encounter or 
relationship in which patient feels that a 
provider cares about them and works in 
their best interest and/or a provider feels a 
patient is reliable and capable of 
contributing to his or her own care 
(Birkhauer et al., 2017).   
 
Table 1.2 
Terms Related to Methodologies Used in Dissertation 
 
Substantive Term Definition 
Metasynthesis A review approach used to synthesize 
findings of studies that are interpretive in 
nature.  Qualitative meta-synthesis can be 
used to aggregate the findings of a variety 
of types of studies including 
phenomenologies, ethnographies, and 
grounded theories (Sandelowski & 
Barroso, 2007). 
Metasummary A form of systematic review in a target 
domain in which the studies are topical or 
thematic summaries of data. Topical 
summaries are at a low level of abstraction 
and include lists of topics. Thematic 
summaries involve more interpretation 
and include a description of themes 
reflecting underlying patterns in the 
participants’ responses (Sandelowski & 
Barroso, 2003). 
Qualitative Description 
 
 
A qualitative method used for obtaining 
straightforward summaries of narrative 
data to provide information needed by  
policy makers and practitioners to address 
clinical concerns (Sandelowski, 2000). 
Content Analysis A family of analytic approaches ranging 
from impressionistic, intuitive, or 
interpretive analyses to systematic, strict 
textual analyses (Rosengren, 1981). 
Purposeful Sampling A technique used in qualitative research to 
identify and select individuals or groups of 
individuals who are knowledgeable about 
or experienced with a phenomenon of 
interest (Creswell & Plano Clark, 2011).  
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Trustworthiness and Credibility Strategies 
Lincoln and Guba (1985) introduced a set of four criteria to ensure the 
trustworthiness and enhance the soundness of qualitative findings.  The criteria are 
credibility, dependability, confirmability, and transferability.  These four criteria 
provided the framework to enhance the trustworthiness of the findings of the dissertation 
research. 
 Credibility is the extent to which findings are closely tied to data and reflect the 
intended focus of the research (Polit & Beck, 2012).  To enhance credibility, the 
researcher met regularly with the dissertation chair throughout data collection and 
analysis of both studies and regularly obtained input from dissertation committee 
members.  Both the perspectives of maternity nurses and pregnant and postpartum 
women were included in Study 2 to ensure well-balanced findings.  
 Dependability is the extent to which the researcher can account for changing 
conditions around the research and the stability of the data over time (Elo et al., 2014).  
To enhance dependability, the researcher maintained a detailed audit trail that chronicled 
methodological and analytic decisions made throughout the study.  
 Confirmability is the extent to which the data accurately represents the 
information provided by the participants rather than created by the researcher (Polit & 
Beck, 2012).  To enhance conformability, all interviews were verified by the interviewer.  
Data analysis was completed in consultation with input from with the dissertation chair 
and dissertation committee members who periodically compared emerging results with 
findings from the original studies in Study 1 and the interview transcripts in Study 2.   
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 Transferability is the extent to which the results can be transferred to other 
settings or contexts (Marshall & Rossman, 2016).  Transferability is determined by the 
research consumer based on detailed descriptions of the sample and setting provided by 
the researcher.  To enhance transferability of Study 1, detailed descriptions of the 
characteristic of the articles in the metasummary were provided.  To enhance the 
transferability of Study 2, the context of this study was thoroughly described with 
detailed descriptions of the participant characteristics and the settings in which the 
interviews were conducted.   
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CHAPTER 2 
Introduction 
 Chapter 2 describes a metasynthesis of published qualitative studies (Study 1) 
using a metasummary approach to classify types of health care encounters experienced by 
pregnant and postpartum women with SUDs (Aim 1) (Renbarger et al., 2019). 
Maternal Substance Use During Pregnancy and Postpartum 
 Maternal substance use in the United States is a significant public health problem 
associated with a number of adverse fetal, neonatal, and maternal health outcomes.  
Substance use during pregnancy has been linked to perinatal and neonatal complications 
such as increased risk for infant mortality, placental abruption, maternal viral infections, 
intrauterine growth restrictions, low infant birth weight, neonate withdrawal symptoms, 
stillbirth, and preterm birth (Cook et al., 2017; Kotelchuck et al., 2017; O’Leary et al., 
2012; Patrick et al., 2017; Riihim€aki et al., 2017; Yazdy et al., 2015).  
 In the United States, women are at greater risk for substance use during their 
reproductive years (ages 18–29 years) than at any other time in their lives (Compton et 
al., 2007).  In 2018, the National Survey on Drug Use and Health revealed that 11.6 % of 
pregnant women in the United States used tobacco products, 9.9 % reported heavy or 
binge alcohol use, and 5.4% used illicit drugs during pregnancy (U.S. Department of 
Health and Human Services, 2019).  Each substance can increase the risk for perinatal 
and neonatal complications (Forray, 2016).  For example, heavy alcohol use has been 
linked to stillbirth, congenital anomalies, low birthweight, and small for gestational age 
newborns, whereas smoking has been linked to low birthweight, placental abruption, and 
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miscarriage. Risks with cocaine use include preterm birth, low birthweight, premature 
rupture of membranes, and placental abruption (Forray, 2016). 
 Maternal substance use during pregnancy has gained increased attention due to 
the current opioid epidemic.  Opioid use during pregnancy more than quadrupled 
increasing from 1.5 per 1,000 hospital deliveries to 6.5 per 1,000 hospital deliveries 
between the years of 1999-2014 (Haight et al., 2018).  A study of 1.1 million women in 
46 states and Washington, D.C. revealed that between the years 2000 and 2007 
approximately one in five women (21.6%) enrolled in Medicaid filled prescriptions for 
opioids during their pregnancy.  The percent of women who filled opioid prescriptions 
during pregnancy increased from 18.5% in 2000 to 22.8% in 2007 (Desai et al., 2014).  
The percent of women admitted to substance use treatment facilities during pregnancy 
who reported a history of prescription opioid misuse increased from 2% in 1992 to 28% 
in 2012 (Martin et al., 2015).  Maternal hospital admissions related to substance use 
increased 33% from 2006 to 2012 - from 13.4 to 17.9 cases per 1,000 admissions (Fingar 
et al., 2015).   
 The increase in opioid and other substance use during pregnancy has resulted in a 
growing number of infants who are experience withdrawal symptoms after birth.  NAS is 
a cluster of withdrawal symptoms that includes irritability, excessive crying, and 
disturbed sleep patterns and can begin at 24 hours after birth or have a delayed onset of 
five to seven days.  As many as 75-90% of infants exposed to opioids in utero will 
experience NAS.  Other substances such as cocaine, barbiturates, and nicotine used 
during pregnancy may increase the severity and length of NAS symptoms in infants 
(Hudak & Tan, 2012).  The term neonatal opioid withdrawal syndrome (NOWS) is a now 
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widely used to refer to infants experiencing withdrawal symptoms specifically from 
prenatal opioid exposure (Klaman et al, 2017).   
 The Agency for Healthcare Research and Quality estimates that NAS increased 
by 300% between the years of 1999 and 2013 – from 1.5 to 6.0 cases per 1,000 hospital 
births (Ko et al., 2016).  Between 2004 and 2014, the total hospital costs in the United 
States related to NAS and covered by Medicaid increased from $65.4 million in 2004 to 
$462 million in 2014 (Winkelman et al., 2018).   
Health Care of Pregnant and Postpartum Women with SUDs  
 Due to the high incidence of substance use during pregnancy and the associated 
health-related implications for mothers and infants, health care providers play a key role 
in maternal child outcomes.  Prenatal services and addiction treatment during pregnancy 
have been linked to better birth outcomes (Cox et al., 2011; Kotelchuck et al., 2017).  
Pregnant and postpartum women with SUDs, however, often report poor relationships 
with their health care providers (Chan & Moriarty, 2010; Gilchrist et al., 2012; Harvey et 
al., 2015; Leppo, 2012; Radcliffe, 2009).  Barriers to positive relationships with health 
care providers include stigma and criminalization of maternal substance use resulting in 
women’s fears of child removal, arrest, and incarceration (Chan & Moriarty, 2010; 
Gilchrist et al., 2012; Harvey et al., 2015; Leppo, 2012).  These barriers can impede 
pregnant and postpartum women with SUDs from receiving high-quality and regular 
health care, which in turn can negatively affect maternal and infant health outcomes 
(Chan & Moriarty, 2010; Gilchrist et al., 2012; Harvey et al., 2015; Leppo, 2012).   
 Because quality health care encounters that overcome barriers and facilitate 
trusting relationships between the women and their providers are needed to combat the 
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negative effects of substance use during pregnancy, an in-depth understanding of the 
health care encounters experienced by pregnant and postpartum women is needed.  A 
number of qualitative studies that describe interactions between pregnant and postpartum 
women with SUDs and health care providers have been conducted, but the findings of 
these studies have not been well synthesized to provide a comprehensive or nuanced 
description of the nature of the encounters.  Such a description would provide needed 
information to develop strategies to improve the health care experiences of this 
population.  The purpose of this review, therefore, is to synthesize the findings of 
published qualitative studies to describe how pregnant and postpartum women with 
SUDs experience health care encounters in prenatal care, labor and delivery, postpartum, 
and nursery/NICU settings.   
Methods 
Design 
 A qualitative metasummary approach as described by Sandelowski and Barroso 
(2003) was used to conduct the synthesis.  This approach is a form of a systematic review 
that combines qualitative findings from previous studies that produced topical or thematic 
summaries of data.  Topical summaries reflect a low level of abstraction and include lists 
of topics covered by the research participants.  Thematic summaries involve more 
interpretation and include a description of themes reflecting latent patterns found in 
participants’ responses.  Unlike qualitative metasynthesis, which is used to summarize 
studies that have more abstract findings and yields highly interpretive renderings of the 
findings, metasummaries yield a straightforward summary of findings at the topic or 
thematic level of abstraction (Sandelowski & Barroso, 2007).   
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 A metasummary approach was chosen for this review for several reasons.  First, a 
preliminary review of the literature on this topic revealed that the many of the studies 
used qualitative methods.  Second, this preliminary review further revealed that most of 
the qualitative studies had yielded findings at the topical or thematic summary level, and 
thus called for a metasummary rather than metasynthesis approach.  Third, 
metasummaries produce straightforward summaries that typically have pragmatic policy 
and practice implications and thus could inform the development of practical strategies to 
improve the health care encounters of pregnant and postpartum women with SUDs.  
 The metasummary included several steps: (1) retrieving research reports and 
creating a cross-study display, (2) extracting the findings, (3) editing the findings, (4) 
grouping the findings and forming abstracted statements, (5) calculating manifest 
frequency effect sizes of the abstracted statements, and (6) developing a taxonomy of 
health care encounters.  
 Retrieving research reports and creating a cross-study display.  First, the 
researcher retrieved research reports and organized key information from each report 
using a cross-study display (Sandelowski & Barroso, 2007).  Research studies were 
eligible for inclusion if they (a) included women who used substances during pregnancy 
and/or postpartum, (b) described the women’s health care encounters in a prenatal care, 
labor and delivery, postpartum, and/or nursery/NICU setting, (c) contained qualitative 
findings regardless of whether the researchers identified the study as qualitative or 
whether the methodology was correctly labeled, (d) were conducted in the United States 
and included women of any race, ethnicity, nationality or class, (e) were published 
between January 1, 2000 and December 31, 2018 (f) were published in a peer-reviewed 
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journal, and (g) were published in English. Studies were excluded if they (a) did not 
contain original qualitative findings or (b) used mixed methods and the qualitative 
findings could not be separated from the quantitative findings. 
 Pregnancy, labor and delivery, postpartum, and nursery/NICU settings were 
chosen as the study aim was to describe health care encounters focused on pregnancy, 
postpartum, and neonatal care as opposed to those focused specifically on substance use 
treatment.  Because cultural differences likely exist in regards to health care encounters 
of pregnant and postpartum women in different regions of the world and identifying these 
differences would be beyond the scope of this metasummary, the sample was limited to 
studies conducted in the United States.  Based on the recommendations of Sandelowski 
and Barroso (2007), studies were not eliminated if the methodology was incorrectly 
identified in the report.  For example, if researchers referred to their methods as grounded 
theory when in fact they used procedures more consistent with another method, such as 
qualitative description, these reports were retained in the metasummary as they could 
contain important findings regardless of how the method was labeled.  Only articles 
written in English were included as it is the primary language of the United States and the 
shared language of the researcher and dissertation committee members.  The starting date 
of January 1, 2000 was chosen because rates of maternal opioid use in the United States 
started to rise dramatically at that time (Patrick et al., 2012), bringing an increased 
focused on substance use by pregnant and postpartum women.  
 The researcher then searched the electronic databases of CINAHL, PsycINFO, 
PubMed, and SocIndex with search terms that were consistent with inclusion criteria.  
The search terms included pregnant OR antenatal OR perinatal OR maternal OR mothers 
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AND "substance abuse" OR "substance use" OR "drug abuse” OR "drug use" OR 
“addiction” OR alcohol OR opioid OR methadone OR Subutex OR Suboxone OR meth 
OR cocaine OR buprenorphine OR "neonatal abstinence syndrome" AND experience OR 
perception OR narrative OR belief OR qualitative.  
 The researcher reviewed the abstracts of the reports revealed in the search to 
eliminate those that did not meet criteria and then examined the full text of the remaining 
reports to determine which would be included in the metasummary.  The final reports 
included in the metasummary were uploaded into a file-sharing platform accessed by all 
team members.  The researcher then created a cross-study display table to organize key 
information from each report (see Table 2.1).  This display table includes the following 
information: author(s), purpose, sample/setting, method, procedures, measures, and 
findings.  The reports were divided among the members of the dissertation committee to 
verify that (a) the report met study criteria and (b) the findings of the report were best 
described as topical or thematic summaries.  All committee members agreed that the 
reports met study criteria and that the findings were either topical or thematic summaries 
as described by Sandelowski and Barroso (2007). 
 Extracting the findings.  The second step included extracting statements of 
findings in the reports that were relevant to health care encounters.  Any statement that 
described how pregnant and/or postpartum women with SUDs experienced health care 
encounters in a prenatal care, labor and delivery, postpartum, or nursery/ NICU setting 
were highlighted and extracted.  The statements were placed in a single file by the 
researcher and confirmed by a dissertation committee member. 
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 Editing the findings.  The third step included editing extracted statements in a 
format that is understandable to readers who have not read the original report 
(Sandelowski & Barroso, 2007).  Editing findings involves staying as close as possible to 
the words of authors to preserve the meanings of the findings.  Each of the extracted 
statements were edited by the researcher into complete declarative sentences that 
included a subject that described the group of women that were the focus of the reports 
(e.g., “Recovering Hispanic mothers addicted to substances with an infant in the 
NICU….”) and a predicate that described the health care encounter (e.g., …. were called 
that “junkie mom” by nurses).  A dissertation committee member reviewed the edited 
statements and made some suggestions for revisions of wording after reviewing the 
original reports. 
 Grouping the findings and forming abstracted statements.  The fourth step 
included grouping all edited statements on similar topics together to see if they 
confirmed, extended, or refuted each other.  This process was carried out in an iterative 
manner by the researcher through discussions with another team member.  Several 
groupings were proposed, discussed, and agreed upon the researcher and a dissertation 
committee member.  All the edited statements in each group were then summarized into 
abstracted statements that captured the similarities of the edited statements in the group 
while retaining their divergence and complexity.  The abstracted statements were then 
divided among the dissertation committee members to verify that the abstracted 
statements were worded in a way that best reflected the edited statements in each group.  
These dissertation committee members recommended some wording changes that were 
incorporated into the final abstracted statements. 
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 Calculating the manifest frequency effect sizes of the abstracted statements. 
The fifth step involved calculating a manifest frequency effect size for each of the 
abstracted statements (Sandelowski & Barroso, 2007).  This effect size is a quantitative 
index of the prevalence of each abstracted statement in the reports and is calculated by 
dividing number of reports containing an abstracted statement by the total number of 
reports in the metasummary.  If two or more studies have common samples that 
contribute to the same abstracted statement, the reports are counted only once in the 
numerator and the denominator. 
 Developing a taxonomy of health care encounters.  The last step involved 
conducting a taxonomic analysis as described by Sandelowski and Barroso (2007) in 
order to present a parsimonious inventory of the range of findings contained in the 
reports.  The researcher synthesized the abstracted statements by first identifying the 
fundamental nature of the encounters reflected in each statement.  Through revisiting the 
edited statements and original reports, discussion, and consensus, the researcher with 
input from dissertation committee members gathered together similar types of encounters 
and labeled each type with a term that best represented the essence of the participants’ 
experiences in the encounters.  The identification, categorization, and labeling of the 
encounters across the abstracted statements resulted in a taxonomy capturing a variety of 
different types of health care encounters experienced by pregnant and postpartum women 
with SUDs.  The researcher returned to the original reports to determine how many 
reports referred to each type of encounter and wrote a narrative description of the types of 
encounters included in the taxonomy.   
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Results 
 The results of the search process are summarized in the PRISMA diagram 
modified from Moher et al. (2009) (Figure 1).  The initial search of the databases yielded 
3,428 results.  A large number (n = 360) of reports were removed because they were 
duplicates.  The titles and abstracts of the remaining 3,068 reports were examined based 
on the review criteria.  A total of 3,045 reports were removed because they (a) did not 
focus on the health care experiences of pregnant and postpartum women with SUDs, (b) 
were not from the women’s perspective, (c) were not published in English, or (d) were 
conducted outside the United States.  Twenty-three reports remained and were included 
in the metasummary.   
 As seen in the cross-study display in Table 2.1, 19 unique study samples were 
represented in the 23 reports.  The sample sizes of the reports ranged from 4 to 38, and 
the ages of participants ranged from 18 to 56 years at the time of the interview.  The 
participants used a variety of prescription and illicit substances during pregnancy and 
postpartum including opioids, methadone, marijuana, heroin, alcohol, methamphetamine, 
cocaine, benzodiazepines, and tobacco.  Some participants reported polysubstance use.  
The majority of the reports (n = 17) were identified as qualitative description, whereas 
the others were identified as phenomenology (n = 2), focused ethnography (n = 1), 
grounded theory (n = 2), and mixed methods (n = 1). 
 The metasummary procedures resulted in 446 edited statements which were 
grouped into 18 abstracted statements.  As seen in Table 2.2, the frequency effect sizes of 
the abstracted statements ranged from .09 to .53.  This table reveals that the findings with 
the highest relative prevalence were related to adverse encounters.  Over half of the 
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reports (53%) revealed that participants felt they were treated poorly by health care 
providers based on providers’ behaviors or comments, half (50%) revealed that 
participants had a general sense of being judged, almost half (45%) revealed participants 
did not get the information they needed, and almost half (43%) revealed participants felt 
their care was suboptimal due to their substance use.  However, approximately two-fifths 
of the reports indicated that at least some of the participants had positive relationships 
with their providers (41%) and received good medical care (39%). 
The Taxonomy of Health Care Encounters 
 The 18 abstracted statements were synthesized into a taxonomy consisting of five 
types of adverse encounters and three types of beneficial encounters.  Table 2.3 displays 
the types of encounters, the abstracted statements that contributed to the identification of 
each type, and the number of reports that referred to each type.  Each type of encounter is 
described below.  Because some reports described encounters with specific types of 
health care providers (e.g., perinatal educators, nurse practitioners, nurses, doctors), some 
referred to providers generically (e.g., health care providers), and some referred to just 
one type of provider (e.g., NICU nurses), all are referred to as health care providers 
unless a result can be associated more specifically with one or more types of providers.   
Adverse Encounters 
 The majority of reports (n = 22) described encounters between participants and 
health care providers that the participants considered to be adverse.  The participants 
considered these encounters unhelpful or detrimental to their health or well-being or to 
have involved difficult or contentious interactions with a provider.  The participants 
typically attributed adverse encounters to the fact that they were known by providers to 
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be “users.”  Five types of adverse encounters were identified: judgmental, disparaging, 
scrutinizing, disempowering, and deficient-care.  
 Judgmental encounters (#2).  Eleven reports described adverse encounters that 
were labeled as judgmental.  In these encounters, participants sensed that providers 
disapproved of the participants’ substance use and looked down on them because of it.  
Although the providers did not overtly express their disapproval, the participants 
nonetheless felt branded as addicts and bad mothers.  For example, women on methadone 
felt providers thought the participants should be able to stop their substance use 
immediately without medication assisted treatment (MAT).  Participants who had infants 
with NAS sensed blame from physicians and nurses when their infants were withdrawing 
and as a result were reluctant to visit them.  Because the participants believed that their 
providers thought poorly of them, the participants felt ashamed, frustrated, angry, 
irritated, and dismissed during health care visits. 
 Disparaging encounters (#1, #16).  Fourteen reports described adverse 
encounters that were labeled as disparaging.  In these encounters, participants observed 
providers engaging in overt behaviors that were blatantly critical or admonishing.  Many 
participants described offensive behaviors or comments by providers.  For example, 
participants reported NICU nurses would roll their eyes, whisper negative comments, and 
call the participants derogatory names such as “that junkie mom” or “methadone mom.” 
These behaviors led some participants to avoid visiting their infants if an offending nurse 
was working that day.  The participants also revealed that providers said harsh things to 
them.  For example, women prescribed MAT reported being told by nurses that women 
should be put in jail for using while pregnant, and other participants revealed that doctors 
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admonished the participants to “get [their] life together.”  These encounters were stressful 
for the participants and resulted in a sense of low self-worth.  Some described feeling like 
a “dirty virus” or “garbage.”   
 Scrutinizing encounters (#7, #8, #9, #17).  Eighteen reports described adverse 
encounters that were labeled as scrutinizing.  In these encounters, participants felt closely 
observed or monitored by health care providers as a result of being identified as a “drug 
user.”  One way in which participants felt scrutinized was through routine drug testing.  
While some participants realized they would be drug tested at prenatal appointments and 
in the hospital, others were unaware of this and were alarmed when it occurred.  They 
feared that if they had a positive drug test, it would be reported and they would be placed 
in jail, lose custody of their children, or be forced to have an abortion.  As a result, some 
avoided prenatal care, skipped appointments, lied about their substance use, scheduled 
appointments when they had not used substances, switched to other substances before 
seeking care, or used other women’s urine for testing.   
 Participants also felt scrutinized when they were with their infants.  Some 
participants with infants in the NICU reported they were not allowed to hold their infants 
or had to ask permission to touch them.  When the participants did hold their infants, they 
suspected the nurses were monitoring the participants to see if they were “high.”  
Participants also felt supervised by the nurses when breastfeeding.  For example, some 
claimed that nurses were pleased when their infants would not latch properly so the 
infants could be given formula.  As a result of this scrutiny, participants were convinced 
that providers questioned their ability to be mothers and felt unwelcomed and out of place 
when they visited their infants.  Some participants were convinced that their relationships 
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with their infants had been damaged because providers had inhibited mother-infant 
bonding.  
 Disempowering encounters (#10, #12).  Ten reports described encounters that 
were labeled as disempowering.  In these encounters, participants felt like they had little 
control over their own health and that of their infants.  The participants indicated that 
their health care providers often did not believe them, listen to them, or take their health-
related concerns seriously.  Many participants objected to not being included in health 
care decisions.  For example, some participants felt they did not have a voice in the type 
of SUD treatment they received during pregnancy and some complained that their MAT 
medication dose was adjusted without their knowledge.  Others indicated that their 
opinions or observations regarding the health of their infants were not considered.  For 
example, some participants recounted instances in which they were worried that 
something was wrong with their infant but a provider dismissed their concerns.  Some 
participants who experienced fetal loss felt it could have been prevented if providers had 
listened.  Participants wanted their voices to be heard and respected and felt frustrated 
and angry as a result of disempowering encounters. 
 Deficient-care encounters (#3, #4).  Fourteen reports described encounters that 
were labeled as deficient-care.  In these encounters, participants felt like they were 
receiving low quality care because of their substance use.  One aspect of deficient care 
was not being provided adequate health information by health care providers.  Some 
participants suggested that they were often not given full explanations of their care, and 
others complained that different providers gave conflicting information.  In particular, the 
participants desired more information about substance use during pregnancy, substance 
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use treatment options, and breastfeeding.  Participants believed that the limited or 
contradictory information they received stemmed in part from providers’ lack of 
experience in caring for women with SUDs.  For example, some participants reported 
that they believed that their providers had never before treated a pregnant woman who 
was taking methadone during pregnancy.  
 Another aspect of care that the participants felt was deficient was the amount of 
time the providers spent with them and their infants.  Some complained that their 
appointments were too short or too infrequent and felt this was because of their status as 
substance users.  Others felt nurses did not spend enough time with their infants during 
withdrawal or treated their infants poorly because of the participants’ substance use.  In 
some instances, participants felt providers gave good care to their infants but poor care to 
the participants.  As a result of deficit-care encounters, participants deemed providers to 
be unsupportive, uncaring, or untrustworthy and often discontinued care.  
Beneficial Encounters 
 A smaller number of reports (n = 18) described encounters between participants 
and health care providers that the participants considered to be beneficial rather than 
adverse.  The participants considered these encounters to have a positive effect on their 
health and well-being or that of their infants.  Three types of beneficial encounters were 
identified: recovery-based, accepting, and effective-care.   
 Recovery-based encounters (#13, #14, #18).  Six reports described beneficial 
encounters that were labeled as recovery-based.  In these encounters, participants felt that 
providers addressed the substance use in a direct but supportive way and encouraged 
substance use treatment.  Instead of only detecting substance use through testing, 
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providers invited and encouraged participants to disclose and openly discuss their 
substance use.  These participants accepted that providers should monitor substance use 
through testing as part of good care.  In recovery-based encounters, providers were 
involved in providing referrals and follow-up for substance use treatment.  Recovery-
based encounters also included interactions in which providers provided support for 
participants’ substance use treatment.  For example, participants appreciated nurses who 
supported methadone treatment and were understanding when participants had to leave 
their infants in the NICU each day to attend the methadone clinic.  Moreover, participants 
were grateful when they had “slips” and providers acknowledged that this was often part 
of the recovery process or when providers gave them “credit” reducing their substance 
use rather than expecting them to quit immediately.  In recovery-based encounters, 
participants felt they could be honest about their substance use and recovery could be 
incorporated into their overall care.  
 Accepting encounters (#5).  Ten reports described beneficial encounters that 
were labeled as accepting.  In these encounters, participants sensed that their providers 
thought favorably of them despite their substance use.  The participants indicated that 
providers conveyed acceptance by not being judgmental, showing empathy and 
consideration, communicating with them respectfully, sharing personal information, and 
treating them the same as patients who did not use substances.  For example, participants 
felt accepted by NICU nurses who performed small but kind gestures such as finding the 
participants a comfortable place for them to sit or asking them how they were doing.  
Participants felt especially accepted by providers who acknowledged their identities as 
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mothers. Accepting encounters could motivate participants to continue with care despite 
logistical challenges such as transportation and distance.   
 Effective-care encounters (#6, #11, #15).  Fifteen reports contained encounters 
that were labeled as effective-care.  In these encounters, participants felt that their health 
care providers were not only accepting but provided care that improved the participants’ 
health and that of their infants in some way.  For example, some participants reported that 
they received helpful information from providers on a variety of health topics such as 
breastfeeding and drug tests and screening.  Another way in which participants felt they 
were receiving effective care was when providers offered practical assistance and advice.  
For example, participants on methadone appreciated it when their providers assisted them 
with breastfeeding.  Participants also believed they were receiving effective care when 
providers provided the opportunity for participants to discuss their concerns.  Some 
participants, for instance, appreciated being able to openly discuss their fears about their 
infants’ health.  Other participants noted that their infants received good nursing care.  
For example, participants were comforted when their infants had their “own nurse” in the 
NICU, and some participants remarked that good nursing care allowed their infants to 
require less medicine for withdraw symptoms.   
Discussion 
 Twenty-three qualitative reports that described the health care encounters of 
pregnant and postpartum women with SUDs were included in the metasummary.  The 
majority of reports indicated that most women with SUDs perceive health care 
encounters to be adverse and relationships with providers to be conflictual.  Five types of 
adverse encounters were identified: judgmental, disparaging, scrutinizing, 
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disempowering, and deficient-care.  The reports also indicated, however, that some 
pregnant and postpartum women with SUDs perceive their health care encounters to be 
beneficial and relationships with providers to be positive.  Three types of beneficial 
encounters were identified: recovery-based, accepting, and effective-care.   
 The findings reveal that pregnant and postpartum women with SUDs believe that 
adverse encounters with providers are fueled by stigma because providers judge women 
harshly when they use substances during pregnancy and thus endanger the health of their 
infants.  This finding resonates with much of the literature on substance use and stigma in 
other health care settings.  For example, a systematic review by van Boekel et al. (2013) 
found that health care providers in Western countries hold negative attitudes towards 
persons with SUDs and that these attitudes negatively affect treatment outcomes and 
patients’ feelings of empowerment.  Moreover, providers perceive that violence, 
manipulation, and poor motivation hinder the health care of persons with SUDs.  The 
review also revealed that providers often lack education and training to work with this 
population.  
 The results indicate that pregnant and postpartum women with SUDs often 
experience negative communication with providers, which is consistent with prior studies 
on substance use and communication in patient-provider relationships.  For example, 
many of the problems in adverse encounters described in the reports in the current review 
stemmed from use of language by providers that the women perceived as judgmental or 
offensive (i.e., “addict,” “methadone mom”).  The finding supports research by Ashford 
et al. (2018) on the impact of word choice on explicit and implicit bias.  They found that 
terms “substance abuser,” “addict,” “alcoholic,” and “opioid addict” are associated with 
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negative bias and should not be used, whereas the use of the terms “recurrence of use” 
and “pharmacotherapy” have positive benefits.  The current findings as well as those by 
Ashford et al. (2018) thus highlight the importance of the use nonbiased language in 
health care encounters with women with SUDs.  The use of derogatory terms is 
detrimental to the engagement of pregnant and postpartum women with SUDs in health 
care and thus can lead to negative consequences for both women and their infants.    
 The current findings revealed that most pregnant and postpartum women with 
SUDs fear the legal consequences of their substances use, especially losing their children.  
A study by Holland et al. (2016) found that obstetric providers of women who used 
marijuana were more likely to focus on the legal rather than the health-related 
consequences of substance use, such as when providers warned women that child 
protective services (CPS) could be called at delivery.  These findings of the current study 
and Holland et al. (2016) study, therefore, indicate that health care providers need to 
carefully consider that discussion on legal consequences may be perceived as threatening 
by pregnant and postpartum women.  Health care providers play a significant role in 
detecting substance use during pregnancy and referring women to appropriate resources 
within their community.  The American Congress of Obstetricians and Gynecologists 
(ACOG) recognizes that punitive laws and actions against pregnant women can serve as a 
barrier to a trusting patient-provider relationship and this may interfere with their care. 
Health care providers should be open and transparent about any testing and reporting 
requirements they may have that could potentially lead to legal consequences for 
pregnant and postpartum women with SUDs.  ACOG recommends that urine drug 
screens be done to confirm substance use and only with consent of the pregnant woman.  
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 The current findings and those of prior studies thus indicate that interventions that 
improve communication between providers and women with SUDs may be needed.  For 
example, Weisner and colleagues (2016) developed an intervention (LINKAGE) to link 
patients receiving addiction treatment to health care.  The intervention includes manual-
guided sessions on patient engagement in health care, the use of health information 
technology, and facilitated communication with physicians.  The positive outcomes of the 
intervention included greater engagement in health care and increased likelihood of 
discussing addiction problems with physicians. 
 The current finding that many pregnant and postpartum women with SUDs desire 
more control over their health care can be viewed through the lens of the concept of 
patient activation, which is the ability of patients to actively engage in managing their 
own health and navigating the health care system (Hibbard et al., 2004).  An important 
aspect of patient activation is shared-decision making, which occurs when providers 
encourage patients to consider and choose among treatment options based on the best 
available evidence (Elwyn et al., 2010).  Shared decision-making as perceived by patients 
has been found to improve affective-cognitive outcomes such as satisfaction and less 
decisional conflict (Shay & Lafata, 2015). 
 The findings of this review revealed that women often experience conflicts 
between pregnancy, postpartum, and neonatal care and substance use treatment.  Perinatal 
health care providers were often not well-informed about addiction and substance use 
treatment, and recovery professionals were often not sensitive to women’s needs during 
pregnancy and postpartum.  These conflicts highlight the need for health systems to 
provide well-coordinated integrated care.  For example, a review by Milligan et al. (2011) 
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found that women with SUDs who participated in integrated care were more likely to 
receive prenatal care and less likely to give birth to premature infants than women who 
did not.  Integrated care included services for pregnancy, parenting, or children in 
combination with substance use treatment in one setting. 
 The findings should be considered in the context of the limitations of the review.  
The level of the findings in all the reports were primarily descriptive and no studies 
produced highly interpretive or theoretically-based findings based on criteria cited by 
Sandelowski and Barroso (2007).  Because the product of a metasummary is to a 
straightforward summary of findings, rather than an abstract rendering of them, a 
theoretical model of how encounters unfold over time was unable to be developed, how 
encounters vary based on the demographic characteristics of the participants, and how the 
context of the health care influences the encounters.  In addition, the findings of the 
reports in the review were based on the participants’ perspectives and information about 
the providers’ views on the encounters were not collected in the studies.  Moreover, 
participants tended to describe the providers’ actions in the encounters but rarely 
discussed their own actions.  Because health care encounters are dynamic interactions 
between providers and patients, investigating these encounters as dyadic exchanges by 
using verbatim recordings of encounters and observations of health care visits would 
yield more nuanced descriptions of adverse and beneficial encounters.   
 Despite the limitations of the review, several clinical recommendations can be 
proposed based on the findings.  First, the findings clearly indicate that health care 
providers should reflect on their own biases regarding women who use substances during 
pregnancy.  Providers in prenatal care, labor and delivery, postpartum, and/or 
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nursery/NICU settings should be aware of their behaviors, either implicit or overt, that 
could be perceived as disparaging by women with SUDs, acknowledge the behaviors as 
harmful, and discontinue them.  Second, perinatal providers should be knowledgeable 
about the complex challenges faced by women with SUDs including the process of 
substance use recovery.  Third, providers should receive education on recognizing and 
managing implicit biases and improving communication with pregnant and postpartum 
women with SUDs in order to improve their health care experiences and ensure that they 
receive regular perinatal care.  Fourth, health care providers should actively include the 
women in health care decisions by promoting patient activation and encouraging shared 
decision-making.  Finally, providers in pregnancy, labor and delivery, postpartum, and 
nursery/NICU settings should collaborate with substance use treatment providers to 
devise a treatment plan aimed at providing optimal outcomes for both mother and infant. 
 In summary, the findings of 23 qualitative reports that described the health care 
encounters of pregnant and postpartum women with SUDs were synthesized using a 
metasummary approach.  While some participants described positive encounters, most 
felt they were treated poorly by providers due to their substance use.  The findings of the 
review resonate with the findings of prior studies that point to the importance of stigma 
awareness, therapeutic provider-patient communication, patient activation, and integrated 
care in this population.  The conclusions of the review are based only on the participants’ 
perspectives and future research should examine dyadic interactions between women 
with SUDs and their providers.  The findings indicate that providers should be aware of 
implicit biases against pregnant and postpartum women with SUDs and provide care 
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informed by best practices regarding treating substance use during pregnancy and 
postpartum.   
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Figure 1  
PRISMA Flow Diagram of Process Selection 
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Table 2.1 
Cross-Study Display Table 
 
Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
Cleveland 
& Bonugli 
(2014) 
The purpose of 
this study was to 
explore the 
NICU 
experiences of 
mothers of 
infants with 
NAS.  
Sample 
15 mothers of infants with 
NAS   
 
Ages: 22-40 year, (M=28)                 
 
Hispanic 
 
Substance use: 
13 participants were 
prescribed methadone at the 
time of the interview. 
 
Setting 
Southwestern Region 
United States 
 
 
Qualitative, 
Descriptive 
Participants were 
recruited from 2 
outpatient 
addiction 
treatment 
facilities.  Flyers 
were distributed 
with contact 
information.  Staff 
were provided 
information at a 
staff in-service at 
each facility.  
Semi-
structured 
interviews 
Participants felt nurses lacked 
understanding of addiction. 
Participants shared feelings of 
guilt and shame when 
observing their infants 
withdrawing.  The participants 
felt judged by the nurses and 
that feeling judged interfered 
with their ability to trust the 
nurses.   
Cleveland 
et al., 
(2016) 
We sought to 
answer the 
following 
research 
question: “What 
are the 
mothering 
experiences of 
women with 
SUDs?” 
Sample 
15 mothers who used 
substances 
 
 Ages: 22-40, (M=28)  
 
Hispanic 
 
Substance use: 
13 were enrolled in a 
methadone maintenance 
program 
 
Qualitative, 
Descriptive 
Participants were 
recruited from 2 
community-based 
treatment facilities 
in a large urban 
city.  Flyers were 
placed at both 
facilities with 
contact 
information.  
Snowball 
sampling was also 
used.   
Semi-
structured 
interviews 
Five themes were identified 
that described the mothering 
experiences of the women and 
included:  1) facing the reality 
of a pregnancy complicated by 
substance use, trauma, and loss 
2) finding a higher meaning 3) 
dealing with the consequences 
4) managing the details of 
daily life 5) looking toward a 
future with my children.  
Mothers described negative 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
Setting 
Southwestern Region 
United States 
interactions with their nurses in 
the hospital.  
Cleveland 
& Gill, 
(2013) 
To describe the 
hospital 
experiences of 
mother who give 
birth to 
substance-
exposed infants. 
Sample 
5 postpartum mothers (2 
weeks to 2 months) 
 
Ages: 22-37 years, (M=32) 
 
Mexican-American  
 
Substance use: methadone 
 
Setting 
 
Southwestern Region 
United States 
 
 
Qualitative, 
Descriptive 
Participants were 
recruited for the 
primary study 
through a variety 
of methods from 
community 
location in a large 
metropolitan area.  
Flyers about the 
study were posted 
throughout the 
community, 
including clinics 
affiliated with a 
large tertiary 
hospital. 
Interviews 4 themes were identified and 
included: 1) try not to judge 2) 
scoring the baby 3) share with 
me and 4) I’m the mother here! 
The quality of the relationship 
between the mothers and the 
nurses in the NICU was a 
significant factor of the 
mothers’ experiences.  
Demirci et 
al., (2015) 
In this analysis, 
we describe the 
experiences and 
perceptions 
impacting 
breastfeeding 
decisions among 
pregnant and 
postpartum 
women taking 
methadone. 
Sample 
7 pregnant women and 4 
postpartum women 
 
Pregnant women only: 
 
Ages: 18 to 45 years, (M=27 
years) 
 
Caucasian 
 
Substance use: prescribed 
methadone 
 
Setting 
United States 
Qualitative; 
Descriptive 
The participants 
were part of a 
larger study and 
recruited through 
advertisements at 
a local substance 
use treatment 
center for 
pregnant women 
and mothers.  
Semi-
structured 
interviews and 
focus groups 
Three major themes were 
identified and included: 1) 
fears, barriers, and 
misconceptions 2) motivation 
and perceived benefits of 
breastfeeding; and 3) sources 
of information, support, and 
anxiety. Participants believed 
health care providers were 
unknowledgeable about 
breastfeeding and methadone 
use. Participants described 
negative interactions with their 
nurses.   
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
Falleta et 
al., (2018) 
This current 
study takes a 
qualitative 
approach to 
understand 
currently or 
recently 
pregnant 
women’s 
perceptions of 
CPS.   
Sample 
16 women 
 
Ages: M= 25.9 years 
 
White (62.5%) 
 
Substance use:  
opioids 
 
Setting 
Ohio 
Qualitative, 
Descriptive 
Participants were 
recruited for the 
study by program 
staff at a substance 
use treatment 
facility in 2012.  
Interviews with 
study participants 
were conducted 
individually by a 
trained clinical 
psychology PhD 
candidate.   
Semi-
structured 
interviews 
Participants identified both 
positive and negative feelings 
and attitudes about CPS. 
Participants identified useful 
qualities of CPS.  Fear can 
serve as a barrier to women 
receiving care.  
Fallin-
Bennett & 
Ashford, 
(2017) 
To collect 
formative 
information to 
design a tailored 
tobacco 
treatment 
intervention for 
women with 
newborns treated 
or evaluated for 
neonatal 
abstinence 
syndrome and to 
explore current 
tobacco use 
behaviors and 
facilitators and 
barriers to 
smoking 
cessation. 
 
Sample 
11 mothers of newborns who 
were treated or evaluated for 
neonatal abstinence 
syndrome at birth within the 
preceding 3 months.  
 
Ages 22-36 years  
 
Substance use:  
opioids 
smoking 
 
Setting 
United States 
 
Qualitative, 
Descriptive 
Participants took 
part in semi-
structured 
individual 
interviews that 
lasted 
approximately 1 
hour. Interviews 
were 
professionally 
transcribed and 
analyzed using 
content analysis 
 
Semi-
structured 
interviews 
Five themes were identified 
and included:  1) strategizing 
to reduce risk 2) desire to quit 
smoking in the future 3) 
holding on to smoking while 
working through recovery 4) 
feeling judged by nurses and 5) 
feeling supported and 
empowered by nurses. 
Most participants described  
positive experiences and were 
supported by health care 
providers. 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
Hicks et al., 
(2018) 
This study 
utilized a cross-
sectional 
qualitative and 
quantitative 
interview-based 
survey to 
capture the 
infant feeding 
practices and 
barriers to 
exclusive 
breastfeeding for 
women in 
methadone 
maintenance 
therapy.  
 
Sample 
30 women in methadone 
maintenance treatment 
 
 
Substance use: methadone  
 
Ages: 22-41 years 
 
Setting 
 
Southeastern Region 
United States 
 
Mixed Methods A convenience 
sample of women 
in treatment 
(n = 30) were 
interviewed using 
an adapted 
instrument 
designed to 
capture decisions 
and intentions to 
formula feed or 
breastfeed; 
support from 
friends and 
family; hospital 
experience; 
support from 
health care 
personnel; and 
maternal 
knowledge of 
breastfeeding 
while taking 
methadone. 
 
Interviews Out of the 24 women who 
initiated breastfeeding, 11 
reported that they discontinued 
because of issues related to 
infant's neonatal intensive care 
unit (NICU) stay. Eleven 
women reported that their 
health care providers did not 
discuss breastfeeding with 
them. Women who were 
encouraged to breastfeed by 
health care staff were more 
likely to breastfeed for longer 
durations. 
 
 Howard, 
(2015) 
This qualitative 
study was 
undertaken to 
examine the 
experiences of 
opioid-
dependent 
women during 
their prenatal 
Sample 
20 postpartum women within 
6 months of delivery 
 
Ages: 18-44 years 
 
Substance use: Prescription 
opioids  
 
Setting 
Qualitative, 
Phenomenology 
Recruitment of the 
postpartum 
patients was 
accomplished 
through 5 
substance use 
treatment centers. 
Flyers were 
displayed in 
public restrooms, 
Interviews Themes developed around 
internal stigma of shame and 
guilt. The majority of women 
reported external stigma from 
health care providers. 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
and early 
postpartum care.  
Maine, Massachusetts, and 
Rhode Island 
 
 
waiting areas, and 
informational 
bulletin boards at 
the treatment 
locations.  
Howard, 
(2016) 
The aim of the 
study was to 
understand the 
lived 
experiences of 
pregnant and 
postpartum 
women who 
have an opioid 
use disorder.  
Sample 
20 postpartum women within 
6 months of delivery 
 
Ages: 20-38 years  
 
Substance use:  
Prescription opioids  
 
Setting 
Maine, Massachusetts, and 
Rhode Island 
 
Qualitative, 
Phenomenology 
Recruitment of the 
postpartum 
patients was 
accomplished 
through 5 
substance use 
treatment centers. 
Flyers were 
displayed in 
public restrooms, 
waiting areas, and 
informational 
bulletin boards at 
the treatment 
locations. 
Interviews Themes included:  1) decision 
making about treatment 
choices during pregnancy 2) 
fear of CPS and 3) feeling 
under surveillance. 
 Jarlenski et 
al., (2016) 
This study 
explored how 
pregnant women 
who use 
marijuana obtain 
and understand 
information 
about perinatal 
marijuana use. 
 
Sample 
26 pregnant women   
 
Ages: 19-36 years 
 
Substance use: 
marijuana 
 
Setting 
United States 
 
Qualitative Interviews 
assessed women's 
sources of 
information about 
risks of perinatal 
marijuana use and 
perceptions 
regarding the 
usefulness of such 
information. 
Interview data 
were coded 
independently by 
two coders who 
iteratively refined 
Semi-
structured 
interviews 
Few women reported receiving 
helpful information from a 
health care provider or social 
worker. Women described a 
lack of evidence about harms 
of perinatal marijuana use, and 
reported being dissatisfied with 
the quality of information. 
Most women said they desired 
information about the effects 
of perinatal marijuana use on 
infant health. 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
the codes and 
reviewed 
transcripts for 
themes.  
 
 Jessup et 
al., (2003) 
To examine 
extrinsic barriers 
to substance use 
treatment 
programs by 
drug dependent 
women. 
Sample 
12 pregnant women and 24 
women who had a child 
within the previous year  
 
Ages: 24.4-36 years 
 
Substance use:  
Crack/powder cocaine 
Alcohol 
Heroin 
Methamphetamine 
Cocaine/marijuana cigarettes 
Psychedelics 
 
Setting 
California 
 
Qualitative,  
Life History 
Analysis 
Participants were 
recruited from 15 
residential 
substance use 
treatment 
programs for 
pregnant and 
parenting women. 
Flyers with a toll-
free telephone 
number were 
posted in the 
programs and a 
telephone-
screening 
interview was 
conducted.  
Life history 
interviews 
Participants fear and worry 
about loss of infant custody, 
arrest, prosecution, and 
incarceration. Participants 
feared presenting for care and 
feared  
not presenting for care. 
 
 
Kramlich et 
al., (2018) 
This focused 
ethnography 
aimed to address 
the 
missing voice of 
pregnant and 
parenting 
women with 
SUDs in rural 
areas.  
 
Sample 
13 women within 5 weeks of 
delivery while infants were 
receiving treatment for NAS 
 
Ages: 22-40 years 
 
Substance use: prescribed 
MAT prescription opioids 
illicit opioid use 
 
Setting 
Qualitative, 
Focused 
Ethnography 
Women were 
recruited for study 
participation in 
two ways, either 
through 
informational 
flyers  
shared by their 
prenatal providers 
or by the inpatient 
perinatal social 
Interviews, 
participant 
observations, 
and media 
artifacts 
Several themes were identified 
as: 1) challenges of getting 
treatment and care (service  
availability, 
distance/geographic location, 
transportation, provider 
collaboration/coordination, 
physical and emotional  
safety), 2) opportunities to 
bond (proximity, information), 
and 3) importance of 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
United States 
 
workers after 
delivery.  
relationships (respect, 
empathy, familiarity,  
inclusion, interactions with 
care providers). 
 
Kuo et al., 
(2013) 
A semi-
structured 
discussion guide 
probed for 
factors 
impacting 
treatment 
outcomes and 
needs.  
Sample 
7 pregnant and  
11 postpartum women (less 
than 6 months) 
 
11 Caucasian 
4 Hispanic 
3 mixed race 
 
Ages: not reported 
 
Substance use: unspecified 
drugs and alcohol 
 
Setting 
United States 
 
 
Qualitative, 
Grounded  
Theory Approach 
Participants were 
recruited from an 
urban 
Northeastern 
outpatient and 
intensive 
outpatient clinic.  
Three focus 
groups were 
conducted with 4-
7 participants per 
group.   
Focus groups Women identified family, 
friend, romantic, and agency 
characteristics as either 
supportive or challenging to 
their recoveries.  
Mattocks et 
al., (2017) 
The purpose of 
this study was to 
explore 
perceptions of 
experiences and 
challenges with 
methadone 
maintenance 
treatment 
Sample 
14 women participated in the 
study; 5 women participated 
in the pregnancy focus group 
and 9 women participated in 
the postpartum focus group.  
 
Ages: 23-36 years, (M=28)  
 
Qualitative, 
Grounded Theory 
Approach 
Two research 
team members 
conducted and 
recorded focus 
groups, which 
took 
approximately 45 
minutes to 1 hour. 
Grounded theory 
2 Focus 
groups 
Five themes were identified as: 
1) guilt, coupled with fear of 
negative outcomes for their 
infant, dictates women's MMT 
treatment decisions; 2) finding 
obstetricians with experience 
treating pregnant women using 
methadone can be a challenge; 
3) methadone clinic physicians 
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Statement 
Sample/Setting Method Procedures Measures Findings 
(MMT) and 
obstetrical care 
among pregnant 
and postpartum 
women enrolled 
in a methadone 
maintenance 
program. 
 
 
80% Caucasian, 
20% Hispanic/Latino. 
 
Substance use: methadone 
 
Setting 
United States 
 
 
was used to guide 
data analysis and 
open coding, 
where transcripts 
were reviewed 
line by line to 
create code 
definitions as 
concepts emerged 
inductively from 
the data.  
 
are instrumental in helping 
women find the right 
methadone dose during 
pregnancy; 4) some women 
had strong preferences for 
methadone over 
buprenorphine; and 5) women 
face substantial substance use 
treatment challenges after 
delivery.  
 
McGlothen 
et al., 
(2018) 
This study 
aimed to 
describe what 
influences the 
infant-feeding 
decisions of 
women taking 
medication 
assisted 
treatment for 
opioid use 
disorder. 
Sample 
8 postpartum women no 
more than 6 weeks post 
delivery 
 
Ages: All over 18 years, 
(M=27 years) 
 
7 participants were Hispanic  
 
Substance use:  
heroin 
MAT treatment 
 
Setting 
Southwestern Region 
United States 
 
Qualitative, 
Descriptive 
Purposeful 
sampling was used 
to recruit 
postpartum 
women.  
Participants were 
provided with a 
recruitment flyer 
about the study 
during prenatal 
classes at the 
treatment center.  
Flyers were also 
posted in the 
newborn nursery, 
neonatal intensive 
care unit, and 
mother-baby unit 
of a county 
hospital. 
Semi-
structured 
interviews 
Two themes were identified as: 
1) what I heard about 
breastfeeding and 2) doing 
what I feel is best for my baby. 
Participants felt there was 
social stigma and that nurses 
undermined their infant-
feeding decision.  
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Statement 
Sample/Setting Method Procedures Measures Findings 
Paterno et 
al., (2018) 
The purpose of 
this study was to 
describe the 
experiences of 
addiction in 
pregnancy, 
recovery, and 
subsequently 
serving as a peer 
mentor to other 
pregnant women 
with active SUD 
among women 
in recovery in a 
rural setting.  
Sample 
5 women who served as peer 
mentors with lived 
experience of perinatal 
SUDs.  
 
Ages: 31-56 years 
 
White 
 
Setting 
United States 
Qualitative, 
Narrative Inquiry 
Peer mentors were 
recruited by word-
of-mouth with 
assistance from 
one peer mentor 
who served as key 
informant.  The 
key informant 
notified other peer 
mentors about the 
study and gave 
them the contact 
information for 
project principal 
investigator.  
Digital 
storytelling 
and semi-
structure 
interviews 
The mentors faced significant 
stigma from health care 
providers and fear during their 
pregnancy.  The mentors had 
each done “inside work” to 
successfully complete 
recovery. They maintained 
recovery by staying balanced.   
Roberts & 
Nuru-Jeter, 
(2010) 
Explore 
women’s 
perspectives on 
being identified 
as a pregnant 
alcohol or drug 
user through 
screening and 
the influence on 
prenatal care 
attendance and 
engagement. 
38 low-income pregnant and 
parenting women  
 
Substance use: 
alcohol methamphetamine  
 
Setting 
California 
 
Qualitative, 
Descriptive 
Purposive 
sampling strategy 
was used.  
Participants were 
recruited from 
programs serving 
low-income 
women.  Staff at 
participating sites 
recruited women 
through posted 
flyers and a 
standardized 
script.  Interviews 
lasted 
approximately 60 
minutes.  
20 semi-
structured 
interviews and 
two focus 
groups 
Most participants were 
opposed to having drug but not 
alcohol use identified by health 
care providers. 
Participants were mistrustful of 
health care providers’ efforts to 
discover substance use and 
expected legal, psychological, 
and social consequences from 
being identified. Some 
participants avoided and 
disengaged from prenatal care 
and attempted to stop using 
substances on their own.  
Roberts & 
Pies, (2011) 
To understand 
how drug use 
and factors 
Sample 
38 pregnant and parenting 
women 
Qualitative, 
Exploratory 
 
Women were 
recruited from 
substance use 
20 semi-
structured 
interviews and 
Most participants avoided 
prenatal care or attempted to 
stop using substances before 
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Statement 
Sample/Setting Method Procedures Measures Findings 
associated with 
drug use 
influence 
women’s 
prenatal care use 
 
Substance use: 
methamphetamine 
crack/cocaine  
alcohol 
 
Setting 
California 
 
 
treatment, a home-
visiting program, 
and the Women, 
Infants, and 
Children program 
by phone or when 
she was onsite.   
2 focus groups 
were 
conducted. 
Case-studies, 
a cross-case 
study, and 
typology were 
also used. 
attending prenatal care because 
of fear of CPS. A few 
participants attended in spite of 
their fear of CPS because they 
prioritized their baby’s health.   
 
 
Salmon et 
al., (2000) 
The purpose of 
this study was to 
explore 
perceptions of 
pregnant and 
parenting 
substance-
abusing women 
in an outpatient 
drug treatment 
program 
regarding 
provider and 
social support. 
 
Sample 
20 women who were 
pregnant/parenting  
 
Ages: 19-37 years; (M=30) 
 
Substance use:  
hallucinogens 
crack-cocaine 
methamphetamines/crank 
marijuana 
alcohol 
prescription substances 
 
Setting 
United States 
Qualitative, 
Descriptive 
Participants were 
recruited through 
an advertisement 
posted at the 
agency. Interviews 
were held in a 
private office of 
an 
outpatient 
substance use 
treatment program 
serving pregnant 
and parenting 
substance-using 
women, designed 
to promote the 
health and normal 
development of 
the children.  
Interviews The majority of participants 
felt the support received from 
medical providers was not 
adequate. The majority of 
participants reported receiving 
no information on risks of 
substance use in pregnancy 
from their health care 
providers.  
 
Scott et al., 
(2017) 
To explore care 
experiences of 
women who 
used prescription 
or illicit opioids 
and experienced 
Sample 
11 women who experienced 
fetal or infant loss 
 
Ages: 18-36 years 
 
Qualitative, 
Description with 
secondary data 
analysis 
The interviews 
were conducted by 
nurses who 
received training 
on how to conduct 
an interview.   
11 interviews Participants felt frustration and 
anger of not being heard by 
their health care providers.  
Participants felt minimized and 
overwhelmed experienced a 
profound sense of grief and 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
fetal or infant 
loss. 
 
White (n=8) 
 
Substance use:  
opioids 
polysubstance use 
 
Setting 
Midwest Region 
United States 
 
 
coping over the loss of their 
children. 
 
Stone, 
(2015) 
To gain a greater 
understanding of 
the way 
substance-using 
women navigate 
the health and 
justice systems 
in order to avoid 
criminal justice 
consequences 
and to access 
needed health 
and social 
support 
resources. 
Sample 
30 pregnant or recently 
pregnant women (within 12 
months postpartum) 
 
Ages: 19-41 years 
 
Substance use:  
alcohol 
marijuana 
prescription medications 
cocaine methamphetamine 
heroin  
hallucinogens 
 
Setting 
United States 
Qualitative, 
Descriptive 
Purposive 
sampling with 
recruitment flyers 
posted in the 
maternity wards of 
local hospitals and 
substance use 
treatment centers, 
community 
centers, and 
service enrollment 
offices. Women 
who completed 
the interviews 
were invited to 
refer others to the 
study.  
In-depth life 
history 
interviews and 
loosely-
structured 
interview 
schedule of 
open-ended 
questions.  
Participants feared detection 
during pregnancy, losing 
custody of their children, and 
experiencing criminal justice 
consequences.  
More than half of the 
participants avoided prenatal 
care.  Participants skipped 
visits, scheduled appointments 
around substance use, or 
avoided prenatal care 
completely. 
 
Suarez et 
al., (2018) 
This qualitative 
interview study 
provides insight 
into the 
experience of 
becoming a 
mother for 
Sample 
4 women with children aged 
14-20 months 
 
Substance use: 
Opiates 
 
Qualitative, 
Narrative 
Approach 
Mothers in a 
larger scale study 
of the impact of 
combined 
occupational and 
music therapies 
were invited to 
Semi-
structured 
interviews 
Themes were identified and 
include 1) deep love for the 
baby, 2) the baby as a 
motivation to stay sober 3) and 
the determination to make the 
relationship between mother 
and child different from the 
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Authors Purpose 
Statement 
Sample/Setting Method Procedures Measures Findings 
women in opiate 
recovery. 
 
Setting 
United States 
 
 
complete 
interviews. All 
four participants 
were in an opiate 
substance use 
recovery program 
and had a baby 
born with NAS.  
 
one the mother had 
experienced with her own 
mother.  Participants described 
stigma from health care 
providers. 
 
Van 
Scoyoc, et 
al., (2016) 
To answer the 
question of why 
pregnant women 
continue to use 
illicit substances 
without 
accessing 
treatment despite 
acknowledging 
the risks to their 
developing 
babies. 
Sample 
15 pregnant or postpartum 
women  
 
Ages: 23-38 years, (M=27.3) 
 
11 Caucasian 
3 Native American 
1 Hispanic 
 
Substance use:  
alcohol  
tobacco 
marijuana methamphetamine 
heroin 
cocaine 
opiates 
 
Setting 
Pacific Northwest Region 
United States 
Qualitative, 
Descriptive 
Women were 
recruited through 
announcements in 
parenting classes, 
referrals by 
treatment staff, 
and flyers posted 
at the treatment 
center.   
Interviews Many participants reported 
having concerns about 
disclosing their addiction to 
health care providers.  
Participants also described 
trying to quit or weaning off 
substances themselves.   
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Table 2.2 
Frequency Effect Sizes 
 
Abstracted Statement Effect Size 
1. Many pregnant and postpartum women with SUDs feel they are 
treated poorly by health care providers as evidenced by their 
disparaging comments and behaviors. (Cleveland et al., 2016; 
Cleveland & Bonugli, 2014; Cleveland & Gill, 2013; Howard, 
2015; Howard, 2016; Jarlenski et al., 2016; Kramlich et al., 
2018; McGlothen et al., 2018; Roberts & Nuru-Jeter, 2010; 
Roberts & Pies, 2011; Salmon et al., 2000; Scott et al., 2017; 
Stone 2015; Suarez et al., 2018) 
.53 
2. During encounters with health care providers, many pregnant 
and postpartum with SUDs women feel judged because of their 
substance use. (Cleveland & Bonugli, 2014; Cleveland & Gill, 
2013; Demirci et al., 2015; Fallin-Bennett & Ashford, 2017; 
Kramlich et al., 2018; Mattocks et al., 2017; McGlothen et al., 
2018; Paterno et al., 2018; Roberts & Nuru-Jeter, 2010; Salmon 
et al., 2000; Suarez et al., 2018) 
.50 
3. Many pregnant and postpartum women with SUDs do not 
receive the information they need to manage their health care, 
often because their providers lack knowledge about substance 
use and pregnancy. (Cleveland & Bonugli, 2014; Demirci et al., 
2015; Howard 2015; Jarlenski et al., 2016; Kramlich et al., 2018; 
Mattocks et al., 2017; McGlothen et al., 2018; Roberts & Nuru-
Jeter, 2010; Roberts & Pies, 2011; Salmon et al., 2000; Scott et 
al., 2017; Stone, 2015)  
.45 
4. Pregnant and postpartum women with SUDs feel providers do 
not provide optimal care, spend enough time with them, or act in 
a manner that is compassionate, trustworthy, and supportive. 
(Cleveland & Bonugli 2014; Cleveland & Gill, 2013; Howard, 
2016; Kramlich et al., 2018; Kuo et al., 2013; Mattocks et al., 
2017; Roberts & Nuru-Jeter, 2010; Roberts & Pies, 2011; 
Salmon et al., 2000; Scott et al., 2017; Stone, 2015) 
.43 
5. Some pregnant and postpartum women with SUDs have positive 
relationships with their health care providers and feel the 
providers do not judge or treat the women differently than 
women without SUDs. (Cleveland & Bonugli, 2014; Cleveland 
& Gill, 2013; Fallin-Bennett & Ashford, 2017; Howard 2015; 
Kramlich et al., 2018; Mattocks et al., 2017; Roberts & Nuru-
Jeter, 2010; Salmon et al., 2000; Stone, 2015; Suarez et al., 
2018) 
.41 
6. Some pregnant and postpartum women with SUDs feel health 
care providers provide good medical care, emotional support, 
and helpful health-related information. (Demirci et al., 2015; 
Fallin-Bennett & Ashford, 2017; Hicks 2018; Howard, 2016;  
.39 
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Abstracted Statement  Effect Size 
     McGlothen et al., 2018; Roberts & Nuru-Jeter, 2010; Salmon et  
     al., 2000; Scott et al., 2017; Suarez et al., 2018) 
 
7. Pregnant and postpartum women with SUDs feel nurses monitor 
the women when they are with their infants or take over the 
infants’ care. (Cleveland et al., 2016; Cleveland & Bonugli, 
2014; Cleveland & Gill, 2013; Demirci et al., 2015; Fallin-
Bennett & Ashford, 2017; Howard, 2015; Kramlich et al., 2018; 
McGlothen et al., 2018; Salmon et al., 2000; Stone 2015)  
.36 
8. Some pregnant and postpartum women with SUDs limit 
substance use before health care appointments, hide substance 
use from providers, and delay or avoid prenatal care to avoid 
detection. (Falletta et al., 2018; Jessup et al., 2003; Kramlich et 
al., 2018; Mattocks et al., 2017; Roberts & Nuru-Jeter, 2010; 
Roberts & Pies, 2011; Stone, 2015; Van Scoyoc et al., 2017)  
.31 
9. Many pregnant and postpartum women with SUDs fear that 
encounters with health care providers could lead to negative 
legal and social consequences stemming from their substance 
use, especially the loss of the women’s children. (Howard, 2015; 
Howard, 2016; Jarlenski et al., 2016; Jessup et al., 2003; Roberts 
& Nuru-Jeter, 2010; Roberts & Pies, 2011; Stone, 2015; Van 
Scoyoc et al., 2017)  
.28 
10. Some pregnant and postpartum women with SUDs feel health 
care providers fail to include the women in decisions about their 
health. (Howard, 2016; Kramlich et al., 2018; McGlothen et al., 
2018; Roberts & Nuru-Jeter, 2010; Scott et al., 2017; Stone, 
2015)  
.26 
11. Some pregnant and postpartum women with SUDs feel that 
health care providers give good care of their infant. (Cleveland 
& Bonugli, 2014; Fallin-Bennett & Ashford, 2017; Mattocks et 
al., 2017; McGlothen et al., 2018; Salmon et al., 2000; Suarez et 
al., 2018)  
.26 
12. Pregnant and postpartum women with SUDs often feel their 
health care providers do not believe, listen to, or consider the 
women’s concerns about their health and that of their infants. 
(Howard, 2015; Paterno et al., 2018; Roberts & Nuru-Jeter, 
2010; Roberts & Pies, 2011; Salmon et al., 2000; Scott et al., 
2017) 
.23 
13. Some pregnant and postpartum women appreciate it when health 
care providers address their substance use and encourage SUD 
treatment. (Kramlich et al., 2018; Mattocks et al., 2017; Roberts 
& Nuru-Jeter, 2010; Salmon et al., 2000; Suarez et al., 2018) 
.22 
14. Some pregnant and postpartum women with SUDs feel it is best 
if their health care providers are aware of their substance use.  
.17 
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Abstracted Statement 
 
Effect Size 
      (Kramlich et al., 2018; Roberts & Nuru-Jeter, 2010; Stone, 2015; 
      Suarez et al., 2018) 
 
15. Pregnant and postpartum women with SUDs who seek prenatal 
health care do so primarily because they are concerned about 
their infants’ health. (Cleveland et al., 2016; Jessup et al., 2003; 
Roberts & Pies, 2011; Stone, 2015) 
.17 
16. Some pregnant and postpartum women with SUDs feel like 
nurses in the NICU treat the women’s infants differently or 
poorly because of the women’s substance use. (Cleveland et al., 
2016; Cleveland & Bonugli, 2014; Cleveland & Gill, 2013; 
Howard, 2015; Kramlich et al., 2018)  
.14 
17. Most pregnant and postpartum women with SUDs are concerned 
about drug testing procedures during health care encounters. 
(Jessup et al., 2003; Roberts & Nuru-Jeter, 2010; Stone, 2015) 
.13 
18. Some pregnant and postpartum women with SUDs see the 
benefits of drug testing. (Roberts & Nuru-Jeter, 2010; Stone, 
2015)  
.09 
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Table 2.3 
Taxonomy of Health Care Encounters 
 
 The abstracted statements (numbered in 
Table 2.2) that contributed to the 
identification of each type of encounter   
Number of 
reports in 
the sample 
that 
discussed 
each type of 
encounter 
Adverse 
Encounters 
  
1. Judgmental 
encounters 
# 2: During encounters with health care 
providers, many pregnant and postpartum with 
SUDs women feel judged because of their 
substance use. 
11 
2. Disparaging 
encounters 
# 1: Many pregnant and postpartum women with 
SUDs feel they are treated poorly by health care 
providers as evidenced by their disparaging 
comments and behaviors. 
 
#16: Some pregnant and postpartum women with 
SUDs feel like nurses in the NICU treat the 
women’s infants differently or poorly because of 
the women’s substance use. 
14 
3. Scrutinizing 
encounters  
#7: Pregnant and postpartum women with SUDs 
feel nurses monitor the women when they are 
with their infants or take over the infants’ care. 
 
#8: Some pregnant and postpartum women with 
SUDs limit substance use before health care 
appointments, hide substance use from providers, 
and delay or avoid prenatal care to avoid 
detection. 
 
#9: Many pregnant and postpartum women with 
SUDs fear that encounters with health care 
providers could lead to negative legal and social 
consequences stemming from their substance 
use, especially the loss of the women’s children. 
 
#17: Most pregnant and postpartum women with 
SUDs are concerned about drug testing 
procedures during health care encounters. 
 
 
18 
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 The abstracted statements (numbered in 
Table 2.2) that contributed to the 
identification of each type of encounter   
Number of 
reports in 
the sample 
that 
discussed 
each type of 
encounter 
 
Adverse 
Encounters 
  
4.Disempowering 
encounters 
 
 
#10: Some pregnant and postpartum women with 
SUDs feel health care providers fail to include 
the women in decisions about their health.  
 
#12: Pregnant and postpartum women with 
SUDs often feel their health care providers do 
not believe, listen to, or consider the women’s 
concerns about their health and that of their 
infants.  
10 
 
 
 
5. Deficient-care 
encounters 
# 3: Many pregnant and postpartum women with 
SUDs do not receive the information they need 
to manage their health care, often because their 
providers lack knowledge about substance use 
and pregnancy. 
 
#4: Pregnant and postpartum women with SUDs 
feel providers do not provide optimal care, spend 
enough time with them, or act in a manner that is 
compassionate, trustworthy, and supportive. 
14 
Beneficial 
Encounters  
  
1. Recovery-
based encounters 
#13: Some pregnant and postpartum women 
appreciate it when health care providers address 
their substance use and encourage SUD 
treatment. 
 
#14: Some pregnant and postpartum women with 
SUDs feel it is best if their health care providers 
are aware of their substance use. 
 
#18: Some pregnant and postpartum women with 
SUDs see the benefits of drug testing. 
6 
2. Accepting 
encounters  
#5: Some pregnant and postpartum women with 
SUDs have positive relationships with their 
health care providers and feel the providers do  
10 
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 The abstracted statements (numbered in 
Table 2.2) that contributed to the 
identification of each type of encounter   
Number of 
reports in 
the sample 
that 
discussed 
each type of 
encounter 
 
Beneficial 
Encounters 
 
  
 not judge or treat the women differently than 
women without SUDs. 
 
3. Effective-care 
encounters 
 
 
 
#6: Some pregnant and postpartum women with 
SUDs feel health care providers provide good 
medical care, emotional support, and helpful 
health-related information. 
 
#11: Some pregnant and postpartum women with 
SUDs feel that health care providers give good 
care of their infant. 
 
#15: Pregnant and postpartum women with 
SUDs who seek prenatal health care do so 
primarily because they are concerned about their 
infants’ health. 
 
 
 
15 
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CHAPTER 3  
Introduction 
 Chapter 3 describes a qualitative descriptive study (Study 2) conducted to identify 
facilitators of and barriers to the formation of trusting relationships between maternity 
nurses and pregnant and postpartum women with SUDs (Aims 2 and 3).   
Maternal Substance Use 
 Substance use during pregnancy is a growing maternal-child health concern in the 
United States.  In a recent national survey by the U.S. Department of Health and Human 
Services (2019), 11.6% of pregnant women reported tobacco use, 9.9% alcohol use, 4.7% 
marijuana use, and 5.4% illicit substance use while pregnant.  Particularly concerning is 
the number of women and children being affected by the current opioid crisis in the 
United States.  Opioid use during pregnancy increased 333% between 1999 and 2014 - 
from 1.5 cases per 1,000 hospital births in 1999 to 6.5 cases per 1,000 hospital births in 
2014 (Haight et al., 2018).  
 Substance use during pregnancy has been linked to variety of maternal, fetal and 
neonatal complications.  Alcohol use during pregnancy is associated microcephaly, 
hydrocephaly, oral clefts, and attention deficit disorder (Pereira et al., 2018).  Tobacco 
use during pregnancy is linked to fetal growth restriction and maternal complications 
such as placenta abruption and hemorrhage (Pereira et al., 2018; Pineles et al., 2016).  
Opioid use in pregnancy is associated with oral clefts, ventricular septal defects, and 
atrial defects (Lind et al., 2017).   
NAS is a common complication experienced by infants who are exposed to 
prenatal substances.  NAS is a cluster of withdrawal symptoms that can involve the 
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central nervous, respiratory, and gastrointestinal systems and includes irritability, 
excessive crying, and tremors.  While most infants exposed to prenatal opioids will 
experience NAS, a variety of other substances such as benzodiazepines, barbiturates, 
alcohol, and nicotine can contribute to symptoms (Hudak & Tan, 2012).  Between 2009 
and 2012, the incidence of NAS increased exponentially in the United States from 3.4 
cases per 1,000 hospital births to 5.8 cases per 1,000 hospital births (Patrick et al., 2015).   
Given the prevalence and serious complications resulting from substance use 
during pregnancy, it is vital to understand the health care experiences of pregnant and 
postpartum women with SUDs.  It is especially important to understand the formation of 
trust between the women and the maternity nurses who provide much of their care.   
Health Care Experiences of Pregnant and Postpartum Women with SUDs  
 Health care services and addiction treatment improve health outcomes for women 
who use substances during pregnancy and their infants.  Prenatal care can decrease the 
risk of neonatal complications including premature delivery, low infant birth weight, and 
small for gestational age in term infants (El-Mohandes et al., 2003).  Substance use 
treatment integrated with prenatal care is associated with lower rates of preterm delivery, 
placental abruption, and intrauterine fetal demises (Goler et al., 2008). 
 A trusting provider-patient relationship occurs when patients feel that their 
providers care about them and work in their best interest, and when providers feel that 
their patients are capable of assuming responsibility for their care (Birkhauer et al., 
2017).  Provider-patient trust has been linked to positive health outcomes such as higher 
quality of life and patient satisfaction (Birkhauer et al., 2017).  Yet pregnant and 
postpartum women with SUDs do not trust providers if the women feel judged because of 
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their substance use.  Women with SUDs have described stigmatizing health care 
encounters in which a provider undermined their decision-making, assigned them 
offensive labels, and provided them differential treatment (Howard, 2015; Howard, 2016; 
Jessup et al., 2003; Leppo, 2012).  As a result, many women with SUDs forego prenatal 
care (Cleveland & Bonguli, 2014; Cleveland & Gill, 2013; Gilchrist et al., 2012; Howard, 
2015; Leppo, 2012; McGlothen et al., 2018; Paterno et al., 2018).  
Relationships Between Maternity Nurses and Women with SUDs  
 Maternity nurses can positively influence the health care experiences of pregnant 
and postpartum women with SUDs.  Maternity nurses care for women during pregnancy, 
labor and delivery, and postpartum as well as care for their infants after birth.  More than 
other health care providers, maternity nurses provide direct physical and emotional care 
to women and their infants and are well poised to offer support, ensure women’s safety, 
and provide education (Lyndon, 2009).   
As with other health care providers, however, relationships between maternity 
nurses and pregnant and postpartum women can be fraught with difficulties when women 
have used substances during pregnancy.  Maternity nurses report concerns that women 
with SUDs are not truthful their substance use, cannot properly care for their infants, and 
blame nurses for their infants’ problems (Fraser et al., 2007; Maguire et al., 2012; 
Murphy-Oikonen et al., 2010; Shaw et al., 2016).  Moreover, some maternity nurses 
report having experienced abusive and threatening behavior from parents and family 
members of infants with NAS (Maguire et al., 2012).   
 Pregnant and postpartum women with SUDs similarly describe difficulties in their 
relationships with maternity nurses.  Postpartum women with SUDs resent it when nurses 
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judge them and consider them to be “bad” mothers because of their substance use or 
when nurses take over the care of their infants (Cleveland & Gill, 2013).  For example, 
some postpartum women with SUDs report feeling unwelcomed and out of place when 
entering the NICU to care for their infants and believe nurses want to care for infants but 
not mothers who used substances (Cleveland & Gill, 2013).   
The lack of trusting relationships between the women and maternity nurses is a 
significant health care problem.  Nurse theorists have long stressed the importance of 
trust in nurse-patient relationships.  For example, Peplau (1997) recognized the 
importance of meeting a patient’s needs for connection through a trusting nurse-patient 
relationship.  The absence of trust in the nurse-patient relationships may compromise 
health outcomes for pregnant and postpartum women with SUDs.  Despite the 
importance of trust in nurse-patient relationships in this population, few studies have 
provided in-depth descriptions of factors that influence its development.  
Study Purpose  
The purpose of this study, therefore, is to identify facilitators and barriers 
associated with the formation of trusting relationships between maternity nurses and 
pregnant and postpartum women with SUDs.  To comprehensively describe these barriers 
and facilitators, it is necessary to explore the relationships from the perspectives of both 
maternity nurses and women with SUDs.  This information can guide the development of 
strategies to be used by maternity nurses to strengthen relationships with pregnant or 
postpartum women with SUDs who receive nursing care. 
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Methods 
Design 
 A qualitative descriptive approach was used to conduct this study.  Qualitative 
description is a low-interpretive approach in which researchers focus on the surface 
meaning of the participants’ words to describe a phenomenon from their perspectives 
(Sandelowski, 2000).  Qualitative description produces a straightforward summary of 
narrative data to provide information needed by policy makers and practitioners to solve 
health-related problems (Sandelowski, 2000).  Because qualitative description provides a 
comprehensive and focused summary of narrative data rather than more abstract 
conceptualizations, semi-structured interviews with individuals or groups are often used 
to collect data (Neergaard et al., 2009) and content analysis is used to analyze the data 
(Sandelowski, 2000).  Because the goal of the current study is to provide a 
straightforward description of common barriers and facilitators associated with the 
formation of trusting relationships between pregnant or postpartum women with SUDs 
and maternity nurses that can readily inform practice, qualitative description was 
determined to be the most appropriate method.    
Sample and Sample Size  
Because the study aimed to identify barriers and facilitators associated with the 
development of trusting relationships from the perspectives of both maternity nurses and 
pregnant and postpartum women with SUDs, the sample included both of these two 
groups.  Sullivan-Bolyai et al. (2005) indicated that most qualitative descriptive studies 
have a moderate sample size of at least 20 participants, although a final sample size 
depends on how many participants are needed to provide ample data to address the 
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research aims.  Therefore, 25 participants (15 nurses, 10 women) were recruited for this 
study.  Approval was obtained from the Indiana University Purdue University at 
Indianapolis Institutional Review Board (IRB), and administrative permissions were 
obtained from the Association of Women’s Health, Obstetric, and Neonatal Nursing 
(AWHONN), which facilitated the recruitment of the nurses, and the maternal treatment 
center where the women were recruited.   
Nurse Participants  
Inclusion criteria.  The inclusion criteria for the nurse participants were as 
follows: 1) had experience working with pregnant and/or postpartum women with SUDs, 
2) held a registered nurse license, and 3) had at least one year of experience working in a 
maternity nursing area including a prenatal office, labor and delivery unit, postpartum 
unit, or a NICU.  The criterion of having at least one year of working experience ensured 
the nurse participants had a variety of interactions with pregnant and postpartum women 
with SUDs.   
Recruitment.  A convenience sample of 15 maternity nurses from the Midwest 
was recruited by purposeful sampling.  Recruitment was done through the local Chapter 
of AWHONN, which is a 501c3 nonprofit, national membership nursing organization 
that supports and promotes the health of women and newborns. E-mail messages were 
sent to all members of the local section of AWHONN by their Chapter Coordinator.  In 
addition, an announcement of the study was posted on the Facebook page of the local 
section of AWHONN.  The e-mail and Facebook announcement briefly described the 
study and invited interested maternity nurses to contact the researcher by cell phone or 
email.   
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Data collection.  The researcher conducted phone interviews with the first 15 
nurses who contacted her as all met inclusion criteria.  A brief demographic questionnaire 
was administered before beginning the interview (see Appendix A).  Nurse participants 
were asked to discuss their experiences working with pregnant and postpartum women 
with SUDs; describe positive, negative, and typical interactions they had had with the 
women; and identify what helped and hindered the formation of trust using a semi-
structured interview guide (see Appendix B).  The interviews, which lasted between 20 
and 30 minutes, were audiotaped and transcribed.  Each participant was given a $30 gift 
card after completing the interview as compensation for their time.  
Women Participants 
Inclusion criteria.  The inclusion criteria for the women participants were as 
follows: 1) 18 years of age or older, 2) used substances during pregnancy, 3) hospitalized 
for labor/delivery or postpartum care or during their infant’s NICU stay, 3) able to speak 
and write in English, and 4) within two years of giving birth to a living child at a hospital.  
The criterion of having given birth at the hospital was to ensure the participants had 
interactions with maternity nurses they could reflect back on, and the criterion of within 
two years of giving birth was to increase the likelihood the participants would recall those 
interactions.   
Recruitment.  Women participants were recruited from a residential maternal 
treatment center for substance use located in the Midwest.  While the residential center is 
located in a rural setting, clients were from rural, urban, and suburban areas around the 
Midwest.  The treatment center admits women with addictions to opioids and other 
substances such as methamphetamines, marijuana, and cocaine.  Women can have up to 
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two of their children ages five and younger live with them during their stay.  Stays at the 
treatment facility may last up to several months.  Treatment can include individual 
counseling, group therapy, and MAT. 
Purposeful sampling techniques were used to recruit a convenience sample of 10 
women.  The researcher met with the unit manager of the residential treatment center to 
review inclusion criteria and study procedures.  The unit manager identified and 
approached women in the treatment center who met eligibility criteria, briefly explained 
the study, and gave them a study brochure.  The unit manager obtained verbal consent 
from the women to be contacted by the researcher.  The researcher then approached 
women interested in participating in the study, explained the study procedures, and, if the 
women were interested, set up a time to conduct the interview.   
Data collection.  Interviews were held with the first 10 women who expressed an 
interest in participating as all met study criteria.  The interviews were conducted in a 
private conference room at the residential treatment center.  After the women completed a 
brief demographic questionnaire (see Appendix A), the researcher, who is an experienced 
maternity nurse, conducted the individual interviews using a semi-structured interview 
guide (see Appendix B).  Women participants were asked to describe their experiences 
with maternity nurses; describe some positive, negative, and typical interactions with 
them; and identify what helped and hindered forming trust.  The interviews, which lasted 
between 20 and 30 minutes, were audio-recorded and transcribed.  Participants were 
given a $30 gift card after completing the interviews as compensation for their time.  
  73 
Data Management and Analysis  
All the interviews were transcribed by an IRB-approved professional 
transcriptionist.  All participant information was de-identified and labeled with a study 
identification number.  
The data from both groups were analyzed jointly.  Data analysis was completed 
by the researcher with the assistance of her dissertation chair and input from the 
dissertation committee members.  A conventional content analysis, in which codes are 
formed inductively from the data, rather than a directed content analysis, in which a set of 
preexisting codes were used to organize the data (Hsieh & Shannon, 2005), was 
conducted in several steps.   
  Step 1: Transcript Review.  The researcher read through all transcripts several 
times to become immersed in the data and obtain a thorough understanding of the nature 
of the relationship between the maternity nurses and the pregnant and postpartum women 
with SUDs.   
 Step 2: Extraction of Text Units.  The researcher highlighted and extracted each 
text unit (e.g., phrase, sentence, story) related to the relationships between the maternity 
nurses and the pregnant and postpartum women with SUDs.   
Step 3: Coding.  Each text unit was assigned a code by the researcher.  The codes 
were verified by the dissertation chair. 
Step 4. Data display.  These codes were placed into a case-by-topic table as 
described by Miles et al. (2013).  The case-by-topic table is structured so that the cases 
are presented on the vertical axis and topics of interest are presented on the horizontal 
axis.  This table was used to organize, condense and display codes according to each 
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topic.  For example, participants were listed on the vertical axis with their assigned ID 
number (e.g., 001, 002) and topics related to the research aims were displayed on the 
horizontal axis (e.g., positive, negative, and typical aspects of the nurse-patient 
relationships, facilitators of trust, barriers to trust). 
Step 5: Categorization.  The researcher, with input from the dissertation chair, 
categorized and summarized the codes in each column.  
Step 6: Narrative summary.  A narrative description of each column, with the 
use of exemplars taken from the transcripts, were constructed by the researcher to answer 
the study aims.  The summaries were reviewed by the dissertation chair and refinements 
were made.  The summaries were then verified by dissertation committee members who 
independently reviewed a subset of the transcripts to ensure the findings were consistent 
with the data.  
Strategies to Enhance the Trustworthiness of the Study Findings 
 Several procedures were used to establishing the trustworthiness of the findings as 
described by Lincoln and Guba (1985).  To ensure the findings were sound, both 
maternity nurses and pregnant and postpartum women with SUDs were included in the 
sample so that both perspectives were represented.  The interview guides were structured 
such that participants were invited to discuss both positive and negative relationships.  
The researcher became immersed in the data, presented emerging analytic ideas to her 
dissertation chair, and routinely returned to the data to test emerging hypotheses.  The 
narratives that described the barriers and facilitators were reviewed the dissertation 
committee members.  To ensure that the findings were dependable and could be repeated, 
the researcher maintained an audit trail that chronicled all methodological and analytic 
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decisions made throughout the study.  A detailed description of the sample is provided so 
that consumers of the research can determine the transferability of the findings to their 
own settings and context.  
Findings 
Sample Description 
  Fifteen maternity nurses participated in the study.  All identified as female. 
Fourteen were White, and one was Black.  They were between the ages of 31 to 55 years 
with the mean age of 41 years; one did not disclose her age.  They had worked in a 
maternal specialty area for an average of 14.2 years of experience, with a range of 2 to 30 
years.  The nurse participants had current or past experiences working in the following 
settings:  antenatal (n =4), labor and delivery unit (n =12), postpartum unit (n =11), 
maternal/fetal transport (n =1), nursery (n =10), NICU or special care nursery (n =7), and 
labor and delivery, postpartum, and recovery unit (LDPR) (n=2).  They were currently 
working in a variety of roles: staff nurse (n = 7), charge nurse (n = 1), nurse practitioner 
(n = 2), lactation consultant (n = 2), management (n = 1), and education (n = 2).   
 Eight of the 10 women participants completed a demographic questionnaire, and 2 
refused.  The following information, therefore, refers to the eight women who provided 
demographic information.  The women were between the ages of 23 and 37 years with a 
mean age of 29 years.  Six were White, one was Black, and one was Hispanic.  They had 
between 2 and 7 children ranging from 8 days to 19 years old.  As required by inclusion 
criteria, all had a child under the age of 2 years old.  The women reported using the 
following substances during their most recent pregnancy: nicotine, methamphetamines, 
opioid pain relievers differently than prescribed or without a prescription, heroin, 
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marijuana, Subutex with and without a prescription, benzodiazepines, and cocaine.  All 
had used more than one substance.  The primary substances for which women received 
treatment were opioids (n=4) and methamphetamine (n=4).  
Description of Interviews 
 Overall, both nurse and women participants were able to recall a number of 
positive and negative nurse-patient interactions.  The majority were forthcoming and 
described specific details about their interactions.  Only a few participants had difficulty 
recalling particular interactions and spoke in more generalized terms.  Nearly all of the 
participants appeared eager for the opportunity to discuss their experiences.  Several 
participants became upset or angry when discussing behaviors and attitudes of the other 
group.   
Nurse and Women Characteristics and Trusting Relationships   
In describing the nurse-patient encounters they had experienced, the participants 
focused on the characteristics of nurses and characteristics of women that affected the 
formation of trusting relationships.  For this paper, characteristics were considered 
attitudes, common behaviors, and proficiencies or deficiencies that each person brings to 
a relationship.  For each characteristic, the participants identified either positive 
manifestations of the characteristic that helped the development of trust (facilitators) or 
negative manifestations of the characteristic that hindered the development of trust 
(barriers).  The characteristics and related facilitators and barriers are listed in Table 3.1 
and described below.  In some cases, the characteristics of the nurses and the women 
were corresponding or complementary (e.g., demeanor toward women – demeanor 
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toward nurses; provision of care – acceptance of care) and are therefore displayed on the 
same row in the table. 
The participants discussed characteristics of both their own group (i.e., women or 
nurses) and that of the other group that affected the formation of trusting relationships.  
Not surprisingly, however, nurse participants were more focused on the women’s 
characteristics and women participants were more focused on the nurses’ characteristics.  
The findings below represent a merger of the perspectives of both groups, but viewpoints 
are attributed to the nurse participants, the women participants, or both groups combined 
(referred to only as “participants”) when indicated.   
Characteristics of Maternity Nurses and Trusting Relationships 
 The participants identified six characteristics of maternity nurses that were 
manifested in ways that could either help or hinder the formation of trusting relationships 
with pregnant and postpartum women with SUDs.  The characteristics included rapport-
building with women, demeanor toward women, provision of care, provision of 
information, attitude toward substance use, and addiction expertise (see Table 3.1).   
Rapport-building with women.  The findings indicated that rapport-building by 
maternity nurses affected the formation of trusting relationships with pregnant and 
postpartum women with SUDs.  Participants indicated that rapport-building was 
manifested by creating a personal connection with the women or keeping a personal 
distance from them.   
Creating a personal connection.  Women participants indicated that trusting 
relationships were facilitated when a nurse created a personal connection with them.  
Women participants described instances when a nurse sat with them, spent extra time 
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with them, shared personal information, and heard their stories.  As a result, they saw the 
nurse as “a supportive friend,” “a mother figure,” or “like a grandma.”  One woman 
participant stated, “Like she’d [her nurse] sit in there, all night with me, and just talk.”   
The nurse participants also described instances when they made a personal 
connection with a woman by sharing personal information, spending ample time with her, 
and relating to her as both a “woman and a mother.”  One nurse who worked in labor and 
delivery and postpartum described such a connection:  
My real mother was actually; I was born to a drug-addicted mom. So, I try 
to show people that you don’t have to stay that way…. You can turn 
yourself around. I try to use, not my own personal struggle, but I try to use 
my story … to message to other people.   
 
Another nurse participant who worked in labor and delivery and postpartum made 
a personal connection to a woman, and, after hearing her story of addiction, realized “that 
could be me.”   
Keeping a personal distance.  Conversely, women participants indicated that a 
barrier to a trusting relationship occurred when a maternity nurse kept a personal distance 
from them.  The women participants described instances in which a nurse provided basic 
care but did not make an effort to talk to them, spend extra time with them, or get to 
know them. One described such an experience: “‘[The nurse would say] ‘Let me see your 
wristband.” And then ‘That’s it … type, type, type, out of room. That’s it.”  Women 
participants described times when a nurse cared for their infant but did interact with 
them.  One stated, “She [a nurse] didn’t really ask about me or anything. Just kind of paid 
no attention to me, which yeah check on my baby.”   
Nurse participants also discussed a number of instances in which they did not 
form a personal connection with women for whom they provided care.  In some cases, 
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the nurse participants attributed this to the women’s substance use.  A nurse participant 
who worked in labor and delivery and postpartum stated, “The mom that was high when 
she came in, I think part of it was because she was high when she got to us.  I feel like 
trying to communicate with her was not possible.”  Nurse participants also described 
having a distant relationship with a woman if they had too many tasks to do or other 
patients to care for at the same time.   
Demeanor toward women.  The findings indicate that the demeanor (outward 
behaviors) of maternity nurses toward pregnant and postpartum women with SUDs 
affected the formation of a trusting relationship.  The participants suggested that the 
demeanor of maternity nurses was manifested by caring or cruel gestures they made 
toward the women. 
Making caring gestures.  Women participants indicated that caring gestures by 
nurses facilitated trusting relationships. These gestures were small acts that a nurse did to 
make them feel comfortable and cared for while in the hospital.  The women participants, 
for example, appreciated it when a nurse spoke kindly toward them, checked on them 
frequently, and accompanied them out of the hospital after discharge.  Women 
participants were especially grateful for caring gestures involving their infants.  For 
example, one women participant said, “She (the nurse) actually set it up to where I could 
see him (infant) on video from (another hospital) to my phone.”  
Nurse participants similarly described making caring gestures toward a woman 
such as giving her a massage, rubbing her back, and giving her a glass of water.  One 
nurse participant described the caring gesture of not always wearing gloves so a woman 
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would not feel dirty: “Obviously, I washed my hands, but if I hand her [the patient] a 
remote, it wasn’t like, ‘Oh my gosh, it just eww, that’s nasty.’”  
Making cruel gestures. Conversely, the women participants indicated that nurses 
made cruel gestures that obviously hindered trusting relationships.  These gestures were 
acts by a nurse that left them feeling degraded and disheartened.  They described 
instances in which a nurse engaged in eye rolling, made disparaging comments, or 
withheld pain medication in a punitive way. The women participants also described times 
when a nurse treated them unkindly because their babies were withdrawing.  For 
example, nurses are responsible for completing a scale to score the severity of infants’ 
withdrawal symptoms, and several women participants indicated a nurse had scored their 
infants poorly to retaliate against the women for their substance use.  One stated, “She [a 
nurse] was lying is what she was doing.  The day before she scores a one, but now she’s 
scoring an eight, and then the next day she’s scoring a one or a zero.”  The women 
participants also mentioned instances when a nurse refused to allow them to see, hold, or 
feed their infant.  One woman participant stated, “So, I would drive up [to the NICU], 
and I would stay one to two hours, and I’d ask to feed her [infant] and hold her. I was told 
I could not hold my baby.”   
The nurse participants described times they felt angry and frustrated toward a 
woman who used substances.  However, they did not mention engaging in cruel gestures 
such as those described by the women participants.  
Provision of care.  The findings indicate that how maternity nurses provide care 
affected the formation of a trusting relationship with pregnant and postpartum women 
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with SUDs.  Participants indicated that provision of care is manifested as either providing 
effective care or limiting care.   
 Providing effective care.  Women participants indicated that trusting relationships 
were facilitated when a nurse effectively met their care needs.  They described instances 
when a nurse started their IVs easily, provided helpful assistance with breastfeeding, and 
assisted them with walking and showering after they delivered their infant.  In some 
instances, their care needs were life-threatening.  One woman participant shared such an 
instance:  
So she [the nurse] was just really quick about getting me taken back there 
[the delivery room] and getting my IV and all that stuff in, to try to get me 
back to the anesthesiologist as soon as possible, which I did make it, 
barely, but she, I guess, stands out for me in that way.  She made things 
get done.   
 
 In regards to providing effective care, the nurse participants often focused on pain 
management.  They stressed the importance of advocating for women so their pain would 
be well managed, telling women when pain medications were due, and bringing their 
medications on time.  One nurse participant who worked in labor and delivery and 
postpartum stated, “Keep their [patients’] medications going, on time, but if you miss a 
dose, even by 30 minutes, that's going to alter your relationship with them.” 
Limiting care.  Women participants indicated a barrier to trusting relationships 
occurred when a nurse limited the care they provided to women because of their 
substance use.  The women participants described instances in which a nurse did not 
bring needed infant supplies, failed to change their bedding, did not respond quickly 
when they asked for help, had difficulty starting their IVs, or withheld their pain 
medication.  One woman participant stated,  
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I had a seizure, well I had three back-to-back seizures.  They [the nurses] 
let me just lay in the bed and they had my fiancé hold one of those tongue 
depressors down on my tongue and let me just, they just let him take care 
of me is what they were doing.   
 
Another woman participant claimed she had to “fight tooth and nail” to get a 
nurse to give the woman pain medication.   
The nurse participants acknowledged instances when they did only “the basics” 
when caring for a woman who used substances.  One nurse participant who worked in 
labor and delivery recalled feeling angry with a woman who had been “partying” and 
delivered her infant in a toilet.  The nurse participant stated,  
I basically would get in and out of her room. Make sure she was stable and 
do the basics, but I didn’t go above and beyond……… I think it was, I 
think from the provider, myself, I think we were kind of washing our 
hands, I hate to say it.  
 
Another nurse participant who worked in labor and delivery stated, “I definitely 
cared for the baby, but I was not going overboard to try to give special care or anything to 
the mother, at that point.” 
Provision of information.  The findings indicate that provision of information by 
maternity nurses affected the formation of trusting relationships with pregnant or 
postpartum women with SUDs.  Participants indicated that provision of information is 
manifested as either keeping women well informed or leaving them in the dark.   
 Keeping women informed.  Women participants indicated that trust was facilitated 
when a nurse provided information on a variety of topics such as breastfeeding and 
substance use, infant withdrawal, infant care, and medications given for substance use.  
They especially appreciated it when a nurse made an extra effort to provide personalized 
education.  For example, one woman participant was particularly grateful when a nurse 
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provided a tailored hand written diet plan rather than “something that she printed off the 
computer.”  However, women participants stressed that a nurse should present 
information as non-judgmental guidance rather than “telling a woman what to do.”   
The nurse participants also indicated that providing information promoted trust.  
One who worked as a lactation consultant described a positive encounter with a woman 
who used marijuana.  The nurse described the effects of marijuana in breastmilk but did 
not insist the woman not breastfeed.  She asserted, “I can’t tell you [woman] what to do.  
I can tell you what will happen.”  
 Keeping women in the dark.  Women participants indicated that a barrier to a 
trusting relationship occurred when a nurse did not provide enough information.  They 
resented it when a nurse did not communicate with them about their care or report on 
their infants’ progress.  Some described an instance in which a nurse just did her “job” 
and then left the room.  One woman participant claimed, “I would ask questions and they 
[the nurses] would just get up and leave.”  Another woman participant was not told if her 
infant had been taken to the nursery or the NICU.  She stated, “They [the nurses] didn’t 
notify me of anything… I was really left in the dark about a lot of things.”    
 The nurse participants did not describe instances in which they purposely 
withheld information but did describe instances when they felt that providing education 
was difficult or impossible.  For example, several nurse participants described difficulty 
in providing education to women who were high when they came to deliver the infant.  
One nurse participant stated, “I felt like parenting education for her [patient] was not 
going to help her, that she was kind of just so far gone.”  
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Attitude toward substance use.  The findings indicate that the attitudes of 
maternity nurses toward substance use affected the formation of trusting relationships 
with pregnant and postpartum women with SUDs.  The participants indicated that 
maternity nurses’ attitude toward substance use, especially in regard to women’s 
culpability for their addiction, was manifested by remarks that either absolved or 
condemned women for their substance use during pregnancy.  
 Absolving women for substance use. Women participants indicated trusting 
relationships were facilitated if a nurse made remarks that absolved women in some way 
for their substance use.  They tended to “beat [themselves] up” for their substance use 
and its effects on their infants and appreciated nurses who made comments that helped 
eased the women’s guilt.  The women participants described times when a nurse 
reassured them they were not bad mothers, that any harm done to their babies was “not so 
bad,” they were doing a good job with their baby, and they could make positive changes 
in their lives.  One woman participant indicated her nurse said,  
It's not just because you've done that [used substances], that doesn’t mean 
you're a bad parent.  There's parents out there beating their kids and doing 
all kinds of crazy stuff…. [Your substance use] doesn’t mean you're bad 
or there's no hope for you.  
 
 Nurse participants also suggested that trust was enhanced if they helped ease a 
woman’s guilt.  One nurse participant who worked as a lactation consultant recalled 
working with a woman who was distraught that her baby tested positive for opioids and 
was experiencing withdraw symptoms.  The nurse participant stated, “We counseled her 
and talked to her a lot and…. counseling to help her overcome her feelings of blame and 
blaming herself for all of this [baby withdrawing].”   
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Condemning women for substance use.  Conversely, women participants indicated 
that any remark by a nurse that condemned them for their substance use was a barrier to a 
trusting relationship.  They were clear they could not trust a nurse who criticized them for 
their substance use or lifestyle or who lectured them about how they could have harmed 
their baby.  These messages annoyed them because they were well aware of this danger.  
One woman participant said, “It really upset me, because I’m already in the situation I 
put myself in, so I don’t need the nurse to remind me, because I already know.”   
Nurse participants admitted that they had at times condemned a woman for her 
substance use, especially because she had endangered the health of her infant.  One nurse 
participant working with a woman in labor and delivery described her frustration when 
having difficulty starting an IV.  The nurse participant explained,  
I just remember it being frustrating, and I’m sure I wasn’t the nicest nurse 
to that patient either.  I was so frustrated that I couldn’t get an IV site in, 
because she had destroyed her veins, and I love doing IVs. 
 
This nurse participant revealed succumbing to the adage “treat her and street her.” 
Other nurse participants referred to women who use substances during pregnancy as 
“methadone moms,” “Suboxone moms,” and “addicts.”   
Addiction expertise.  The findings indicate that the addiction expertise of 
maternity nurses affected the formation of trusting relationships with pregnant and 
postpartum women with SUDs.  The participants distinguished maternity nurses who had 
addiction expertise from those who did not.  
Having addiction expertise.  Women participants suggested that trusting 
relationships were facilitated when a nurse had knowledge about addictions and 
experience caring for women who struggled with addiction.  They indicated a nurse with 
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addictions expertise understood the women’s difficulties and was more likely to support 
addiction treatment.  For example, they described incidents in which a nurse praised them 
for entering treatment and assured them that this was “the right step.”  One woman 
participant stated, “When I left the hospital with him [her infant], they [the nurses] knew 
that I was going to treatment and they were just really supportive about it.”  The women 
participants suggested that nurses who had a family member with addiction were more 
compassionate because that nurse truly “understood” addiction.   
 Lacking addiction expertise.  Some women participants indicated that a nurse’s 
lack of addiction expertise was a barrier to a trusting relationship because the nurse could 
not to understand women’s struggles. One woman participant stated, “They [nurses] don't 
understand.  Some of them, I think they should be trained for addiction.  That would be 
really nice.”  They suggested that pain management was especially problematic when a 
nurse lacked addiction expertise.  One nurse had offered a woman participant an opioid 
pain medication instead of a preferable alternative pain management approach.  The 
participant stated, “She [the nurse] was giving me Dilaudid and everything else, so that’s 
just bad all around.  And she still brought it.  So, I wasn’t going to turn it down, but I 
wish she would have said no.”   
 The nurse participants also recognized that nurses often lacked addiction 
expertise.  Many indicated they had not had any formal addiction training.  Realizing it 
was important, a few had sought training outside of their place of employment.  One 
nurse who worked in LDPR unit said, “You have to hope that your nurse knows that 
methadone and Nubain will react the way that [they] will, because several nurses have 
given it, even knowing the patient was on methadone.” 
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Characteristics of Women with SUDs and Trusting Relationships 
The participants identified five characteristics of pregnant and postpartum women 
with SUDs that were manifested in ways that could either help or hinder the formation of 
trusting relationships with maternity nurses.  The characteristics included engagement 
with nurses, demeanor towards nurses, acceptance of care, investment in recovery, and 
bonding with infant (see Table 3.1).  
Engagement with nurses.  The findings indicate that engagement by pregnant 
and postpartum women with SUDs with maternity nurses affected the formation of a 
trusting relationship.  Participants suggested that engagement with maternity nurses was 
manifested by women either being open and forthcoming, especially about their 
substance use, or by being closed and distant.  
 Being open and forthcoming.  Women participants indicated that trusting 
relationships were facilitated when they were able to engage with a nurse by “sharing 
their stories” and having the nurse do the same.  One women participant stated, “We [she 
and the nurse] were connected, we were able to sit and have like heart-to-heart 
conversations.”  Another woman participant stated, “We [she and a nurse] sat down and 
cried together for two hours.  Because she’d share a story about her daughter, and I’d 
share a story about myself.”  
 The nurse participants felt they were better able to engage with a woman who 
used substances if she was open, honest, and forthcoming about her substance use and her 
situation.  One nurse participant who worked in LDPR described a woman who was 
particularly open about her substance use.  The participant said, “And just to have that 
trust between us, like she’s telling me something that she knows could be an issue.”  
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Another nurse participant stated, “She [woman who used substances] was open and a lot 
of the nurses, I think at that point, our mind frame kind of shifted as far as what we 
thought about the [typical woman with addictions].”  
 Being closed and distant.  Women participants did not mention instances when 
they were closed or distant in a way that hindered a relationship with a nurse.  However, 
nurse participants indicated a woman’s detachment served as a barrier to forming trust.  
The nurse participants describe instances in which a woman did not talk, make eye 
contact, or interact with them or requested they leave the room.  One nurse participant 
who worked in labor and delivery recalled a woman she cared for during a cesarean 
section: “She just had this blank look on her face, and I remember her kind of rolling her 
eyes, [as if to say] “like whatever.’”  Another nurse participant who worked in 
postpartum explained,  
It was as if you [a nurse] would walk in and say, ‘Hey, good morning.  
How are you?  Can I get you anything?’  And it was just as if the end of 
the world was near, and you had done the worst possible thing to them, 
and they didn’t want to be bothered, and they didn’t want to talk, and it 
was just [like they felt], ‘Do what you need to do and get out, or do you 
have to do this?  Can I refuse this?  Get out. 
 
 Demeanor toward nurses.  The findings indicate that the demeanor of pregnant 
and postpartum women toward maternity nurses affected the development of trusting 
relationships.  Participants suggested that women’s demeanor was manifested in either 
pleasant behaviors or hostile behaviors. 
 Displaying pleasant behaviors.  The women participants did not mention times 
when they displayed pleasant behaviors that furthered trust in their relationships with a 
nurse.  Nurse participants, however, did describe how it was easier to form a trusting 
relationship when a woman engaged in pleasant behaviors.  They described instances 
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when a woman was thankful for the care she received, behaved in a manner that was 
amiable, displayed a positive attitude, and did not complain.  One nurse participant who 
worked in postpartum recalled offering to watch a woman’s baby so she could walk 
around the hospital unit to relieve her pain.  She stated, “And when she [woman] called 
me to bring her baby back, she was expressing how grateful she was.”  Another nurse 
participant who worked as a lactation consult stated, “She [woman] said, “Thanks for 
giving me the information,’ and she was positive about it………. I felt good about that 
answer, because at least she wasn’t being awful and rude and upset.”   
 Displaying hostile behaviors.  The women participants did not mention engaging 
in hostile behaviors that impeded a trusting relationship with a nurse.  The nurse 
participants, however, discussed having difficulty establishing a trusting relationship with 
a woman who appeared hostile.  They described instances in which a woman was 
argumentative, cursed, lied, attacked them, or acted “hateful.”  One nurse participant who 
worked in labor and delivery recalled working with a woman who was transferred to a 
psychiatric unit.  The participant stated, “She [the woman] looked up at me, and I was 
behind the glass window.  She looked up at me and if looks could kill, oh my gosh.”  
Another nurse participant who worked in labor and delivery recalled an incident in which 
a woman’s aggressive behavior had dire consequences:  
She [woman] was out of control, came in and delivered precipitously.  I 
went to give her IM Pitocin after delivery and I gave it to her and she 
swatted at me and I ended up poking myself.  That was my first dirty 
needle stick.  
 
 The nurse participant disclosed that woman had hepatitis C and that the 
participant had to have lab draws for a year following the incident.   
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 Acceptance of care.  The findings indicate that the attitudes of pregnant and 
postpartum women toward receiving help was important in the development of trusting 
relationships with maternity nurses.  Participants suggested that these attitudes were 
manifested by women either accepting or rejecting help offered by a nurse.   
 Accepting help.  Women participants did not mention times when accepting help 
from a nurse fostered trust.  Nurse participants, however, described times when a trusting 
relationship was facilitated when a woman accepted their help.  They described being 
pleased when a woman was “compliant” with her MAT for substance use, was open to 
receiving help, and did “what she was asked to do.”  One nurse participant who worked 
in postpartum stated, “She [woman] was very compliant, there all the time [at hospital 
visiting her infant].  She was kind of what I gauged everything moving forward on.”  
Another nurse who worked in a LDPR spoke fondly of a woman who “never refused 
anything from me. I took care of her multiple times.  She just did what she was told and 
took whatever medicines we were giving her that she was supposed to……” 
 Rejecting help.  The woman participants did not mention instances when a 
trusting relationship with a nurse was impeded because they refused help.  Nurse 
participants, however, indicated that they were unlikely to form a trusting relationship 
with a woman who rejected their help.  They described instances in which a woman was 
not “compliant” or refused care. One nurse participant who worked in labor and delivery 
stated, “That [caring for a woman who was high] was not a great experience, because she 
was so far gone that she did not want help.”  Another nurse described a “typical” woman 
who was not receptive to the participant’s help: “She was always wanting this and 
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wanting that, or not listening to what I had to say, not letting me to do what I need to do 
as far as taking care of her.”  
  Investment in recovery.  The findings indicate that pregnant and postpartum 
women’s investment in recovery affected the development of trusting relationships with 
maternity nurses.  Participants suggested that women were either committed to recovery 
or they continued to actively use substances.   
 Commitment to recovery.  Woman participants described times when their 
relationship with a nurse was facilitated if they showed a committed to recovery.  For 
example, one woman participant stated, “They [the nurses] were all encouraging when 
they found out that I was coming to rehab…”  
 Nurse participants confirmed that they were more likely to form a trusting 
relationship with a woman who expressed a desire for sobriety, attempted to stop using 
substances, stopped using street substances, or sought treatment for substance use.  In 
these situations, the nurse participants typically responded with praise and 
encouragement.  A nurse participant who worked in LDPR stated, “So I felt like she 
[patient] was very brave and very in-tune with her body, and in control of her body, and 
she was willing to do whatever it took to fix this, whereas most people aren’t.”  Another 
nurse participant who worked in labor and delivery described feeling proud of a woman 
who decided to seek help for her substance use: “I think she was using pain pills or 
something like that, and she knew that she had a problem. She got herself going to the 
methadone clinic.” 
 Actively using substances.  Women participants did not describe instances when 
their active substance use interfered with their relationship with a nurse.  Nurse 
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participants, however, described having difficulty trusting women who were actively 
using substances.  They described times when a woman used substances in her hospital 
room, left the nursing unit to get high, was high when she delivered her infant, did not 
attempt to stop her substance use, and did not demonstrate a willingness to change her 
current situation.  The nurse participants described how these behaviors made them 
angry, distrustful, and dismissive of the woman.  One nurse participant who worked in 
labor and delivery described a situation in which a woman left the hospital unit and came 
back with “pills in her pocket.”  The nurse participant stated, “But the fact that she, I 
couldn’t give her anything because I didn’t know what she took downstairs.  That's all I 
can say about that. I lost trust with her, definitely.”  Another nurse participant described a 
woman who hid heroin in the back of the toilet.  She stated, “So, you get anxious around 
those patients, and clearly, they’re lying to you, so you don’t trust them.”   
Bonding with infant.  The findings indicate that how pregnant and postpartum 
women bonded with their infants affected the development of a trusting relationship with 
maternity nurses.  Participants suggested that how women bonded with their infants was 
manifested by how the women showed concern or lack of concern for their infants.   
 Showing concern for infant.  Women participants did not suggest that showing 
concern for their infants facilitated a trusting relationship with a nurse.  Nurse 
participants, however, described how a trusting relationship with a woman was facilitated 
if she showed love for her infant, participated in her infant’s care, showed interest in her 
infant, wanted to comfort her infant, breastfed her infant, or showed remorse for her 
infant’s withdrawal symptoms.  One nurse participant who worked in labor and delivery 
stated, “She [women who used substances] loved her baby, the way I loved my babies, so 
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I could identify with that.”  She went on to say, “She was trying to take care of herself 
and take care of her baby and she didn’t want to lose the relationship [with her husband] 
over it, so I felt like a connection there.”  
 Showing lack of concern for infant.  Women participants did not discuss not 
showing concern for their infants.  Nurse participants, however, commented that some 
women did not show concern for their infants and this impeded the formation of trust.  
The nurse participants described instances when a woman left her infant in the NICU or 
nursery, did not comfort her infant, did not visit her infant in the NICU, did not 
participate in the care of her infant, or left her infant at the hospital for CPS to find the 
infant a home.  These behaviors made it difficult for the nurse participants to connect 
with the women.  One nurse participant who worked in labor and delivery, postpartum, 
and nursery stated,  
It was just difficult to watch and try to encourage [the woman] to spend 
time [with infant], but she was one that had a brick wall up and she would 
leave her room and go outside for a cigarette or whatever and then come 
back, but just not really want to take care of her baby.   
 
Another nurse participant who worked in labor and delivery described a woman who did 
not visit her infant in the NICU.  She stated,  
There was a mom, we would try to call her and call her and call her, and 
she just wouldn’t answer or she'd answer and have kind of a weak excuse 
for not being able to get to the hospital.  It would just be frustrating. 
 
Discussion 
 Fifteen maternity nurses and 10 women with SUDs during pregnancy and 
postpartum were interviewed to identify facilitators and barriers to the development of 
trusting nurse-patient relationships.  The findings revealed that six characteristics of 
maternity nurses and five characteristics of the pregnant and postpartum women with 
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SUDs influenced the building of trust.  The six nurse characteristics are (1) rapport-
building with women, (2) demeanor toward women, (3) provision of care, (4) provision 
of information, (5) attitude toward substance use, and (6) addiction expertise.  The five 
women characteristics are (1) engagement with nurses, (2) demeanor toward nurses, (3) 
acceptance of care, (4) investment in recovery, and (5) bonding with infant.   
 A primary finding was that pregnant and postpartum women with SUDs trusted 
maternity nurses who showed caring, both by connecting with the women in a personal 
way (rapport-building with women) and engaging in caring acts (demeanor towards 
women), and distrusted nurses who did not show such caring.  This finding echoes the 
findings of other published studies with general patient populations.  For example, a 
literature review on trust in nurse-patient relationships by Dinc and Gastmans (2013) 
found that trust is a relational phenomenon associated with nurses showing a “sensitive 
and caring attitude” (p. 509).  Similar to the current findings, this review revealed that the 
depersonalization of the patient hinders the development a trusting nurse-patient 
relationship.  Also consistent with the current findings, a review of literature by Shattell 
(2004) found that patients describe positive experiences when their nurses make eye 
contact, are enthusiastic, and are willing to talk about their own lives.  A systematic 
review by Rørtveit et al. (2015) also revealed that trust was experienced by patients who 
felt a nurse cared about them, accepted them as people, created a sense of belonging, and 
did not diminish them.  
 Another major finding of the current study was that trust developed when the 
maternity nurses provided competent care for pregnant and postpartum women with 
SUDs, both in carrying out direct care activities (provision of care) and in providing 
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education (provision of information), and trust was hindered if the women perceived care 
to be incompetent.  This also resonates with published studies with general patient 
populations.  The literature review by Dinc and Gastmans (2013) revealed that trust 
develops when nurses have the ability to anticipate and meet care needs of patients, are 
prompt, follow through meeting care needs, and provide good advice.  As found in the 
current study, this review also revealed that nurses’ lack of knowledge or practice skills 
serves as a barrier to forming a trusting relationship.  Rørtveit et al. (2015) also found that 
trust is facilitated when patients felt their nurses were competent and knowledgeable. 
 A third major finding of the current study was that pregnant and postpartum 
women trusted nurses who incorporated an understanding of addictions in providing care 
because they had experience working with patients with addictions (addiction expertise) 
and did not blame the women for their substance use (attitude toward substance use), and 
did not trust nurses who did not incorporate an understanding of addictions in their care.  
Other studies have shown that nurses’ lack of addiction knowledge negatively influenced 
their relationships with pregnant and postpartum women with SUDs (Cleveland & 
Bonguli, 2014; Demirci et al., 2015).  Conversely, several studies have found that women 
who use substances were comfortable with nurses who had an understanding of the 
complex issues that surround addiction (Cleveland & Bonguli, 2014; Mattocks et al., 
2017; Suarez et al., 2017). 
 The results of the current study contribute to the literature by providing examples 
of how characteristics of patients who use substances affect nurse-patient relationships, 
an issue that has not been widely addressed.  The findings suggest that trusting nurse-
patient relationships are more likely to occur when pregnant and postpartum women with 
  96 
SUDs are open (engagement with nurses) and amiable (demeanor toward nurses), viewed 
by nurses as “compliant” (acceptance of care), and committed to giving up substances 
(commitment to recovery).  Nurses are more likely to detach from women are distant, 
hostile, “non-compliant” with care, or actively using substances.  These results echo a 
review of literature by Shattell (2004) on nurse-patient interactions that found nurses 
distanced themselves and provided lower quality of care with patients that they viewed as 
“bad” or “difficult.”  
 Some limitations need to be considered in regards to the findings.  First, a 
limitation of the study is that the data were obtained retrospectively as both women and 
nurse participants in the study were asked to recall nurse-patient interactions that 
occurred in the past and might not have been able to recall some details due to the lapses 
in time and memory.  Despite this potential limitation, with the exception of a few 
participants who did struggle to recall specific interactions, most were able to provide 
robust details of the interactions that they recalled, likely because the interactions were 
important to them.  Moreover, the findings were limited by the convenience sampling 
strategy as the women participants and nurse participants were both recruited from single 
venues (i.e., AWHONN, treatment center).  As a result, the lack of diversity within each 
sample limited conclusions that could be drawn.  For example, because the majority of 
participants from both groups were White, no conclusions can be made in regards to the 
effects of ethnicity on the formation of trusting relationships.  In addition, all the women 
participants were in treatment and it is possible that women who do not choose treatment 
may have had different relationships with nurses than those that do.  Similarly, the nurse 
participants were all members of AWHONN and thus may have more knowledgeable 
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about addictions and committed to professional advancement than nurses who do not 
belong to professional organizations.  Another limitation of this study is that not 
surprisingly both groups, but especially the women, were more likely to reflect on how 
the characteristics of the other group, rather than their own, influenced trust.   
Because of these limitations, future research on nurse-patient relationships in this 
population should be prospective; include larger, more diverse samples; examine the 
health care experiences of women throughout the period of perinatal care; include women 
who do not receive addiction treatment; and recruit maternity nurses from a variety of 
venues.  Moreover, to more objectively describe nurse-patient encounters in this 
population, future studies should include a component in which encounters are observed, 
recorded, and analyzed to gain a more nuanced description of how the encounters unfold 
in real time.   
 The findings suggest three clinical implications for maternity nurses.  First, they 
should consider how the nurse characteristics outlined in these findings are evidenced in 
their own nursing care of pregnant and postpartum women with SUDs.  In working with 
this population, maternity nurses need to be attuned to how they might best use caring, 
empathetic, and nonjudgmental approaches.  There were a few women in our sample who 
trusted their maternity nurses fully and experienced no barriers to care, and their 
experiences provide examples of best practices in providing care for this population.  Our 
findings suggest, however, that some nurses may need to enhance their interpersonal 
skills when working with this population.  Delaney, Shattell, and Johnson (2017) 
identified a model of interpersonal engagement based on Peplau’s theory of interpersonal 
skills that includes six core elements: centering yourself, sending intent to listen, 
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displaying empathy, becoming attuned to the patient, decoding and understanding the 
patient’s story, and crafting a response.  The goal of the model is to understand and 
validate the patient’s experience and could serve as a framework for interacting with 
women with SUDs.  Alexander (2017) suggested that providing compassionate care for 
women with addictions is enhanced by listening to their stories, reflecting on their stories, 
and affirming the women.  
Second, maternity nurses should be knowledgeable about the challenges 
surrounding addiction and pregnancy through formal certification programs and 
professional development opportunities.  Organizations that offer such education include 
the International Nurses Society on Addictions (n.d.), the Substance Abuse Mental Health 
Services Administration (U.S. Department of Health and Human Services, n.d.), and the 
American Psychiatric Nurses Association (2019).  Schools of nursing need to include 
comprehensive addiction training especially related to the provision of care for pregnant 
and postpartum women with SUDs.   
Third, maternity nurses may need professional role support to overcome barriers 
to caring for pregnant and postpartum women with SUDs – especially barriers 
encountered in caring for women who do not fit the norm of the “good patient.”  Support 
from other nurses and inter-professional colleagues can help nurses confront any biases 
that interfere caring for patients with SUDs (Neville & Roan, 2014).  Maternity nurses 
need opportunities to develop strategies to form trusting relationships with pregnant and 
postpartum women with SUDs and to improve the quality of care they provide for them 
and their infants. 
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Summary 
 A qualitative descriptive approach (Sandelowski, 2000) was used to identify 
facilitators and barriers associated with the formation of trust between pregnant and 
postpartum women with SUDs and maternity nurses.  Interviews were held with 10 
women who had used substances during pregnancy and 15 nurses who worked in a 
variety of maternity settings.  Using content analysis, six characteristics of nurses and 
five characteristics of women that either facilitated or hindered a trusting relationship 
were identified.  Consistent with prior studies, findings revealed that trust was facilitated 
by maternity nurses who formed a caring connection, provided quality nursing care, and 
had expertise in addiction care and impeded by maternity nurses who did not have these 
characteristics.  Trusting relationships were hindered when the women did not connect 
well with the nurses, rejected care, and showed little interest in recovery or connecting 
with their infants.  The primary limitations of the study include the retrospective nature of 
data collection and the convenience sampling strategies.  The findings suggest that 
maternity nurses should be provided opportunities to examine their biases related to the 
use of substances during pregnancy, develop strategies to provide the most 
compassionate and effective care to this population, and obtain education related to 
addictions in pregnancy.   
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Table 3.1 
Facilitators and Barriers to a Trusting Relationship 
 
Nurse 
Characteristics 
Facilitators Barriers Women 
Characteristics 
Facilitators Barriers 
      
Rapport-
building with 
women 
Creating a 
personal 
connection 
 
Keeping a 
personal 
distance 
Engagement 
with nurses 
Being open 
and 
forthcoming 
Being closed 
and distant 
Demeanor 
toward women 
Making 
caring 
gestures 
 
Making cruel 
gestures 
Demeanor 
toward nurses 
Displaying 
pleasant 
behaviors 
Displaying 
hostile 
behaviors 
Provision of care Providing 
effective care 
Limiting care Acceptance of 
care 
Accepting 
help  
Rejecting 
help  
Provision of 
information 
Keeping 
women 
informed  
 
Keeping 
women in 
the dark 
   
Attitude        
toward 
substance use 
Absolving 
women for 
substance use 
Condemning 
women for 
substance 
use 
Investment in 
recovery 
Commitment 
to recovery 
Actively 
using 
substances 
Addiction 
expertise 
 
Having 
addiction 
expertise 
Lacking 
addiction 
expertise 
   
   Bonding with 
infant 
Showing 
concern for 
infant 
Showing 
lack of 
concern for 
infant 
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CHAPTER 4 
Introduction 
 The purpose of this dissertation was to explore the health care experiences of 
women with SUDs during pregnancy and postpartum.  Two studies were conducted.  
Study 1 (Chapter 2) was a metasynthesis of qualitative literature conducted to develop a 
taxonomy of health care encounters experienced by pregnant and postpartum women 
with SUDs.  Study 2 (Chapter 3) was an empirical study conducted to more specifically 
examine the relationship between pregnant and postpartum women with SUDs and 
maternity nurses, focusing on facilitators and barriers associated with the development of 
trust in these relationships.  This chapter contains a synthesis of the findings of Study 1 
and Study 2, a discussion of how the findings link to Peplau’s theory of interpersonal 
relationships, a description of strengths and limitations of the two studies, and a summary 
of implications for future research, theory, clinical practice, and policy.   
Synthesis of Findings 
 The findings of Study 1 included eight types of health care encounters 
experienced by pregnant and postpartum women with SUDs.  The findings of Study 2 
built upon these findings by identifying six nurse characteristics and five patient 
characteristics that influenced the development of trust in encounters between maternity 
nurses and pregnant and postpartum women with SUDs.  While Study 1 examined 
encounters with health care providers in general, and Study 2 examined encounters with 
maternity nurses in particular, there was resonance across both sets of findings.  
Therefore, the findings of both studies can be synthesized into three key findings.  These 
key findings are discussed below.  
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Key Finding 1: Adverse encounters between health care providers and pregnant and 
postpartum women with SUDs are common, but not universal, and often reflect stigma 
associated with substance use.   
 Four types of encounters identified in Study 1 – judgmental, disparaging, 
scrutinizing, and disempowering – were associated with perceived stigma related to 
substance use.  The women suggested that providers looked down on them, were overtly 
critical of them, closely monitored them, and denied them control over their health care 
decisions because they used substances when pregnant.  Study 2 expanded upon these 
findings by identifying behaviors of maternity nurses that hindered trust and were 
associated with stigma, including keeping a personal distance from the women and 
making cruel gestures toward them.  Study 2 also expanded on the findings of Study 1 by 
identifying behaviors of the women that inhibited trust and exacerbated stigmatizing 
encounters, including being closed and distant and displaying hostility toward nurses.  
These behaviors seemed to fit the nurses’ negative stereotypes of persons who use 
substances.  Taken together, the findings of both studies indicate that stigma related to 
substance use influences health care encounters in profound ways.   
 However, one type of encounter identified in Study 1 – accepting encounters -
indicates that some women did not feel providers looked down on them because of their 
substance use.  These women indicated that their health care providers did not judge 
them, communicated with them respectfully, shared personal information with them, and 
treated them the same as other patients who did not use substances.  Study 2 built on 
these findings by revealing some maternity nurses created a personal connection and 
made caring gestures toward the women and some women were open and forthcoming 
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with nurses and displayed pleasant behaviors.  Together these findings indicate that, 
although less common, some health care encounters between pregnant and postpartum 
are marked by good interpersonal connections rather than stigma.  
Key Finding 2: Adverse encounters between health care providers and pregnant and 
postpartum women with SUDs often, but not always, include not only negative 
interpersonal interactions but perceived lower quality of care. 
 One type of encounter identified in Study 1 – deficient-care encounters – was 
associated with compromised care.  The women indicated that providers spent less time 
with them because they used substances and gave them less information than other 
women.  Study 2 supported this finding by revealing maternity nurses often limited the 
care they provided the women and kept them in dark about their health, and women with 
SUDs often rejected the help nurses offered them.  These findings jointly suggest that the 
health care outcome of lower perceived quality care is an important problem in this 
population.  
Of note, however, one type of encounter identified in Study 1 – effective-care 
encounters – indicates that at least some women did not feel their care was compromised 
because they used substances.  These women indicated they were informed about their 
care and that of their infants, provided with useful health information, given practical 
assistance and advice, and provided with the opportunity to discuss their concerns.  
Similarly, Study 2 revealed that some women felt maternity nurses provided effective 
care and kept them informed and some women readily accepted the help nurses offered 
them.  Both sets of findings indicate some pregnant and postpartum women do perceive 
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their care is effective, although not as commonly as women feel their care is 
compromised because of their substance use.   
Key Finding 3: The addiction expertise of health care providers influence the types of 
encounters experienced between health care providers and pregnant and postpartum 
women with SUDs.   
 The extent to which providers had expertise in addictions influenced all the types 
of encounters identified in Study 1.  The women believed that encounters with providers 
without addiction expertise were more likely to be stigmatizing and to result in poor care.  
Study 2 expanded upon this finding by revealing that some maternity nurses lacked 
addiction expertise and condemned women for their substance use and this was 
exacerbated when women were actively using substances.  Findings from both studies 
thus indicate that providers’ lack of addiction expertise related to the care of pregnant and 
postpartum women with SUDs is an important workforce issue. 
 However, one type of encounter identified in Study 1- recovery-based – indicates 
that some women felt supported by providers who addressed the women’s substance use 
in a direct manner and encouraged them to attend substance use treatment.  Study 2 
findings were consistent as results revealed that some maternity nurses had addiction 
expertise and helped women resolve the guilt they felt for using substances, especially if 
the women were committed to recovery.  Taken together, these findings indicate that 
some providers do have addiction expertise that positively influences their encounters 
with pregnant and postpartum women with SUDs.  
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Study Findings and Peplau’s Theory of Interpersonal Relationship 
 The findings of this dissertation study support several premises of Peplau’s 
(1952,1988,1997) theory of interpersonal relations.  One of the major premises is that 
trust in essential in establishing the nurse-patient relationship.  Consistent with this 
premise, the findings of Study 2 revealed that pregnant and postpartum women with 
SUDs were able to form a trusting relationship with maternity nurses who created a 
personal connection with women, made caring gestures toward them, provided effective 
care, kept them informed, absolved them of guilt associated with substance use, and had 
addiction expertise.  Another major premise of the theory was that nurses should view 
their patients as people rather than as medical conditions, and nurses need to have 
knowledge about what is important to patients.   Study 2 indicated that pregnant and 
postpartum women with SUDs developed trusting relationships with nurses who created 
a personal connection with the women, spent extra time with them, shared personal 
information with them, and listened to their stories.  These activities reflected efforts by 
nurses to get to know the women not just as patients who used substances but as women 
with unique life experiences, needs and struggles.  A third major premise of the theory 
that is reflected in the study findings is that nurses face challenges that can interfere with 
establishing the nurse-patient relationship.  Study 2 uncovered several of these 
challenges; some nurses held negative attitudes toward the women because of their 
substance use, avoided dealing their difficult behaviors, used disrespectful or judgmental 
modes of addressing them, and avoided making a personal connection with them.   
Some of the findings of the studies, however, extended beyond the main premises 
of the theory of interpersonal relationships (1952,1988,1997).  For example, the theory 
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focused on nurse-patient relationships that occur in stages over time, whereas many of the 
encounters described by the participants, especially in Study 2, were brief or one-time 
interactions.  In addition, Peplau’s theory (1997) does not address extensively how the 
patients’ behaviors contribute to the nurse-patient interactions and these behaviors were 
an important focus of Study 2.  These limitations have implications for further theory 
development as will be discussed below. 
Strengths and Innovation 
 The findings of this dissertation expand the current literature by providing in-
depth descriptions of types of health care encounters experienced by pregnant and 
postpartum women with SUDS and a delineation of the facilitators of and barriers to the 
development of trusting relationships with maternity nurses.  These descriptions 
contribute to our understanding of how women’s substance use during pregnancy can 
impact these encounters and affect the women’s health care experiences due to the stigma 
associated with substance use in general and, more specifically, substance use during 
pregnancy.   
 The findings of Study 1 contribute to the literature by providing a synthesis of 
existing qualitative study findings of how pregnant and postpartum women experience 
health care encounters in prenatal care, labor and delivery, postpartum, and 
nursery/NICU setting.  Sandelowski and Barroso (2007) argued that the findings of 
qualitative studies are underutilized because the findings of individual studies on the 
same topic are often not linked in a systematic way and therefore interpretations that can 
be drawn from any one study are limited.  Linking the findings of multiple studies 
through systematic qualitative metasynthesis increases their interpretive value and can 
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make a greater contribution to evidence-based practice.  The taxonomy developed in 
Study 1 is based on many studies with samples of varying sizes and therefore provides a 
more solid foundation from which to draw conclusions than any one study on its own.  
Because a metasummary approach was used, the study produced straightforward 
narrative descriptions of the types of encounters and these descriptions can be used to 
inform policy, practice, and research.  
 The findings of Study 2 will also contribute to the literature in important ways.  
Study 2 is the first study to explore in-depth the development of trust between maternity 
nurses and pregnant and postpartum women with SUDs.  Including the perspectives of 
both the women and maternity nurses allowed for a balance of perspectives and a rich 
discussion related to trust in the nurse-patient relationship.  Despite the sensitive topic, 
both the women and the nurses were easily recruited to the study, seemingly because the 
topic was of concern to them.  The researcher’s background as a maternity nurse also 
seemed to promote rapport with the participants.  Most all of the participants of the 
interview study were open and freely shared their experiences and thus the findings are 
based on rich and informative descriptions of health care encounters.  The structure of the 
interview guide, which ensured participants were invited to discuss both positive and 
negative experiences, added to the comprehensiveness of the findings.  Other 
methodological strengths of both studies included extensive peer debriefing with the 
researcher’s dissertation chair and committee, which enriched the findings and enhanced 
the validity of the study.  
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Limitations 
 The findings of this dissertation are best understood within the context of 
limitations.  The data sets of Study 1 or Study 2 were not large and/or heterogeneous 
enough to draw conclusions about group influences on the health care experiences of the 
participants.  Because most of the primary studies in the metasummary of Study 1 did not 
routinely address sociodemographic variation in their samples, and the two samples of 
Study 2 were relative homogenous and drawn from single venues, the studies did not 
account for how the health care experiences were influenced by demographic 
characteristics such as age, race, religion, and other factors or by type of maternity setting 
(e.g., labor and delivery versus postpartum). 
Additional limitations of the Study 1 were as follows: (a) The findings in all the 
reports were primarily descriptive versus theoretical or interpretive, thereby limiting the 
opportunity to advance theory regarding the phenomenon, and (b) The findings of the 
primary reports were based solely on women’s perspectives and did not include 
providers’ perspectives thus limiting an understanding of how providers viewed the 
women’s contributions to the encounters.   
Additional limitations for Study 2 were as follows: (a) Data were obtained 
retrospectively which increased the risk of recall bias, (b) Because of our recruitment 
strategies, conclusions cannot be made about the views of maternity nurses who do not 
participate in a professional organizations or pregnant and postpartum with SUDs who 
are not in treatment for their substance use, and (c) Both the nurse and women 
participants were more likely to reflect on the characteristics of the other group rather 
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than their own characteristics which restricted our description of some of the barriers and 
facilitators.  
Research Implications 
 Future studies should be conducted that address the limitations of the studies of 
this dissertation.  The next step in this research trajectory is to conduct studies that (a) 
include larger samples with more diverse demographic characteristics, (b) explore 
differences among different maternity settings, and (c) observe or record health care 
encounters in real-time.  Studies aimed at developing a theoretical framework that 
describes how health care encounters unfold over time is needed.  Such a framework 
could be used to develop interventions aimed at improving the quality of relationships 
between health care providers and pregnant and postpartum women with SUDs.  Once 
these interventions are developed, research would focus on evaluating their efficacy and 
effectiveness.  
Clinical Implications 
 While more research is needed to develop theoretically based interventions to 
improve the health care encounters of pregnant and postpartum women with SUDs, the 
findings of this dissertation do support a number of clinical implications for health care 
providers.  The following recommendations are based on the three key findings. 
First, because the findings indicate that pregnant and postpartum women often 
experience adverse encounters due to the stigma associated with the use of substances 
during pregnancy, all health care providers who work with this population should reflect 
on the influence of stigma on their own attitudes and behaviors.  Providers should first 
examine whether their interactions women who use substances could be perceived as 
  
111 
disapproving or judgmental by the women.  As biases against women who use substances 
may be unconscious and difficult to recognize, providers should seek educational and 
training programs on ways to mitigate the influence of implicit bias in their practice and 
improve patient-provider communication related to the sensitive topic of substance use 
during pregnancy.  For example, the intervention LINKAGE, which was developed by 
Weisner and colleagues (2016), has been shown to improve patient engagement and 
communication with physicians who work with patients with SUDs.   
 Second, because findings indicate that many pregnant and postpartum women 
with SUDs perceive their care to be compromised because they use substances, providers 
should evaluate their own practices and seek out supervision and peer support to ensure 
they are not compromising the care they provide to the women and their infants.  Quality 
care needs to include fully informing woman of their health status and care plan, 
empowering them to make decisions regarding their care and promoting activation, 
spending adequate time when caring for them, and carrying out all care tasks, such as 
starting IVs and managing the women’s pain, in a professional and efficient manner.  
Providers in pregnancy, labor and delivery, postpartum, and nursery/NICU settings 
should collaborate with substance use treatment providers to devise a treatment plan 
aimed at providing optimal outcomes for mother and infant. 
 Third, because findings indicate that lack of provider expertise in addiction care 
contributes to adverse encounters and deficient maternity care, providers should obtain 
this expertise through a variety of venues. Professional school curricula should include 
comprehensive content on addictions and provide adequate clinical opportunities in all 
maternity settings for students to obtain the knowledge and skills needed to provide 
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addiction care.  Practicing health care providers should seek opportunities to learn more 
about addictions through professional certifications such as offered by Substance Abuse 
Mental Health Services Administration (U.S. Department of Health and Human Services, 
n.d.) and other health organizations.  Moreover, providers should also be aware of 
addiction resources that are available to women during pregnancy and postpartum 
including community substance use treatment centers, MAT providers, and other local 
programs that provide recovery support.   
Public Policy Implications 
 Study findings indicate that policies such as the criminalization of substance use 
during pregnancy and the removal of children by CPS can affect women’s relationships 
with health care providers.  Women distrust providers who the women fear might report 
their substance use and, in some instances, avoid care because of this.  Health care 
providers should advocate for policies that protect and promote the health of pregnant 
and postpartum women with SUDs and improve maternal-child health outcomes.  
Policies should support recovery rather than punishment, encourage women to disclose 
their substance use during pregnancy, and support women who seek substance use 
treatment while pregnant.  Treatment for SUDs during pregnancy should be readily 
accessible to women and should be coordinated with their maternity care.  Because 
treatment programs are not readily available for all women, providers need to advocate 
for funding for these recovery programs, especially residential maternal treatment 
programs where women can live with their children during their recovery.  
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Conclusion 
 The findings of this dissertation reveal that pregnant and postpartum women with 
SUDs often experience a number of different types of adverse and beneficial health care 
encounters with their health care providers.  The adverse encounters are often influenced 
by the stigma related to use of substances during pregnancy.  The findings also reveal that 
a variety of characteristics of maternity nurses and pregnant and postpartum women 
either help or hinder the development of trusting nurse-patient relationships.  The 
findings of this dissertation study support Peplau’s (1952,1988,1997) theory of 
interpersonal relations, which focuses on the importance of trust, personal connection, 
and knowledge of the person in the provider-patient relationship.  Additional research on 
the health care experiences of pregnant and postpartum women with SUDs is needed to 
build theory and development interventions to improve the health care of this population.  
Clinical recommendations include education, training, supervision, and support in 
mitigating implicit bias, improving communication skills, and providing addictions care.  
Advocating for public policies that support recovery and promote the optimal health care 
outcomes for women and their infants is recommended. 
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Appendix A 
 
Demographic Sheets 
 
Nurse Participants 
 
1. What is your age? 
 __________________________________________________________________ 
 
2. What is your ethnicity? 
      __________________________________________________________________ 
 
3. Do you affiliate with a religious group?  If so, which religion? 
      __________________________________________________________________ 
 
4. What is your gender? 
      __________________________________________________________________ 
 
5. What is your estimated annual household income? 
 __________________________________________________________________ 
 
6. What setting do you work in currently? 
      __________________________________________________________________ 
 
7.  What is your role? (e.g., staff nurse, charge nurse, office nurse?) 
___________________________________________________________________ 
 
8.  What areas of maternity nursing have you worked in in the past? 
___________________________________________________________________ 
  
9. How many years of experience do you have working in a maternity area? 
 
      __________________________________________________________________ 
 
10. How many years of nursing experience have you had? 
 
_________________________________________________________________  
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Women Participants 
 
1. How old are you?    _________________________________________________ 
 
2. What is your race or ethnicity?  ________________________________________ 
 
3. What was the highest level of education that you have  
  completed? _______________________________________________________ 
 
4. How many children do you have?  _____________________________________ 
 
5. How old are your children?   __________________________________________ 
 
6. Did you use any of the following during your pregnancy?  
 
 
Opioids Yes  No Unsure/ No answer 
Methamphetamine Yes No Unsure/ No answer 
Nicotine Yes No Unsure/ No answer 
Heroin Yes No Unsure/No answer 
Cocaine Yes No Unsure/ No answer 
Prescription pain 
killers without a 
prescription 
Yes No Unsure/No answer 
Prescription pain 
killers differently 
than prescribed 
Yes No Unsure/No answer 
Benzodiazepines Yes  No Unsure/No answer 
Alcohol Yes  No Unsure/No answer 
Marijuana Yes No Unsure/No answer 
Methadone: 
with a prescription 
without a prescription 
 
Yes 
Yes 
 
No 
No 
 
Unsure/ No answer 
Unsure/No answer 
Suboxone: 
with a prescription 
without a prescription 
 
Yes 
Yes 
 
No 
No 
 
Unsure/No answer 
Unsure/No answer 
Subutex: 
with a prescription 
without a prescription 
 
Yes 
Yes 
 
No 
No 
 
Unsure/No answer 
Unsure/No answer 
Other (please list): 
 
 
 
Yes No Unsure/ No answer 
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Appendix B 
 
Interview Guides 
 
Maternity Nurse Interview Guide 
 
-Hi, my name is Kalyn and I am registered nurse and a PhD student at Indiana 
School of Nursing.  I want to thank you for participating in this study. I am 
interested in understanding the nature of relationships between maternity nurses 
and pregnant and postpartum women with SUDs.  The answers you provide will 
be useful in identifying ways in which we as nurses can improve our 
relationships with pregnant and postpartum women with SUDs.   As you know, I 
am going to ask you questions about your relationship with pregnant and 
postpartum women with SUDs when working as a maternity nurse. 
 
-You have experience working in a [prenatal, labor and delivery, postpartum, or 
NICU setting].  Tell me about your experiences working with [pregnant and/or 
postpartum] women with SUD’s.  
 
-Our nursing research has indicated that nurses can have positive, not so 
positive, and typical interactions with pregnant/postpartum women with SUDs. I 
am going to ask you to talk about a positive interaction, a not so positive 
interaction, and typical or routine interaction with women with SUDs while 
working as their nurse. Without telling me the women’s names, I am going to 
ask you think back to some specific pregnant or postpartum women with SUDs 
for whom you provided care and the interactions you had with them.  
 
-I would like you to think of an interaction that you had with pregnant or 
postpartum women that you would consider positive. Describe that interaction – 
how did it begin, what happened during the interaction, what was most 
memorable about it, what made it positive? What substances can you recall that 
this patient had been identified as using in pregnancy? (Ask if there are other 
positive interactions the participant would like to discuss and repeat the same 
questions.) 
 
-I would like you to think of an interaction that you had with pregnant or 
postpartum women that was not so positive. Describe that interaction – how did 
it begin, what happened during the interaction, what was most memorable about 
it, what made it not so positive? What substances can you recall that this patient 
had been identified as using in pregnancy? (Ask if there are other not so positive 
interactions the participant would like to discuss and repeat the same questions.) 
 
-I would like you to think of an interaction that you had with pregnant or 
postpartum women that you might consider typical – not necessarily positive or 
negative but routine. Describe that interaction – how did it begin, what happened 
during the interaction, what was most memorable about it, what made it typical? 
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What substances can you recall that this patient had been identified as using in 
pregnancy? (Ask if there are typical interactions the participant would like to 
discuss and repeat the same questions.) 
 
-We believe it is important that maternity nurses and women develop trusting 
relationships but are not quite sure what helps the development of trusting 
relationships.  Thinking back to the relationships you had with pregnant and 
postpartum women you have cared for, were there certain things that helped you 
develop trust with them?   
 
-Were there certain things that got in the way of you developing trust with them? 
 
-Are there any ways in which the women’s substance use influenced your 
relationships with them?  If so, give me some examples of when this occurred. 
 
-Are there any things that you believe would be important for maternity nurses 
to know that would help them provide better care for women during pregnancy 
and postpartum?  
 
-What type of addiction training or education have you received while working 
as a nurse?  
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Women Participant Interview Guide 
 
-Hi, my name is Kalyn and I am registered nurse and a PhD student at Indiana 
School of Nursing.  I want to thank you for participating in this study. I am 
interested in understanding interactions that new mothers have with nurses 
before, during, and after the birth of a child.  The answers you provide will be 
useful in identifying ways nurses can be more helpful when working with new 
mothers. As you know, I am going to ask you questions about your relationship 
with your maternity nurses when [baby’s name] was born.  
 
-[Baby’s name] is now ___ months old.  Tell me about [baby’s name].  
 
-Take me back to the time when [baby’s name] was born. Tell me about what 
your hospital experience was like when [baby’s name] was born.  
 
-We are really interested in understanding all sorts of experiences mothers have 
with their maternity nurses. We would like to hear about several interactions that 
you had with your nurses.  Sometimes new mothers’ interactions with their 
nurses are positive, while others are not so positive, and others are typical or 
routine. Take a moment to think back to your health care experiences 
surrounding your pregnancy and birth of [baby’s name].  I would like you to 
think of an interaction that you had with a maternity nurse that you would 
consider positive. Describe that interaction – how did it begin, what happened 
during the interaction, what was most memorable about it, what made it 
positive? (Ask if there are other positive interactions the participant would like 
to discuss and repeat the same questions.) 
 
-Now I would like you to think back to an interaction that you had with a nurse 
that was not so positive – for any reason. Describe that interaction – how did it 
begin, what happened during the interaction, what was most memorable about it, 
what made it not so positive? (Ask if there are other not so positive interactions 
the participant would like to discuss and repeat the same questions.) 
 
-Now I would like you to think back to an interaction that you had with a nurse 
that was neither especially positive or not so positive – one that was routine or 
typical. Describe that interaction – how did it begin, what happened during the 
interaction, why would you describe it as typical, what made it typical? (Ask if 
there are other routine or typical interactions the participant would like to 
discuss and repeat the same questions.) 
We believe it is important that maternity nurses and women develop trusting 
relationships but are not quite sure what helps the development of trusting 
relationships.  Thinking back to the relationships you had with your nurses, were 
there certain things that helped you develop trust in your nurses?   
 
-Were there certain things that got in the way of you developing trust in your 
nurses? 
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-As you know, we are conducting this study with women who used substances 
during pregnancy or postpartum.  Were there any ways in which your substance 
use influenced your relationships with your nurses?  If so, give me some 
examples of when this occurred. 
 
-Are there any things that you believe would be important for maternity nurses 
to know that would help them provide better care for women during pregnancy 
and postpartum?  
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